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Résumé 
Les sites apuriniques/apyrimidinique (AP) représentent une forme de 
dommage à l’ADN hautement mutagène et ce type de dommage peut survenir 
spontanément ou être induit par une variété d’agents. Afin de préserver la stabilité 
génomique, deux familles d’endonucléases de type AP, endo-IV et exo-III, sont 
nécessaires pour contrecarrer les effets mutagènes des sites AP. Malgré 
l’identification de membres des deux familles dans plusieurs organismes 
unicellulaire tels que E.coli et S. cerevisiae, aucun membre de la famille endo-IV 
n’a été identifié chez les organismes multicellulaires à l’exception de C. elegans et 
de C. briggsae. Nous avons donc décidé d’investiguer l’importance biologique de 
APN-1 chez C. elegans par l’utilisation d’une approche de knockdown du gène. 
Dans notre étude, nous avons montré que le knockdown du gène apn-1 chez C. 
elegans, en utilisant des ARN d’interférence (ARNi), cause une accumulation de 
mutations spontanées et induites par des drogues résultant en un délai de l’éclosion 
des œufs ainsi que par une diminution de la survie et de la longévité des vers 
adultes. De plus, nous avons montré que cette accumulation de mutations mène à 
un délai dans la progression du cycle cellulaire durant l’embryogénèse, 
représentant possiblement une explication du délai dans l’éclosion des œufs. Nous 
avons montré qu’il y avait une augmentation du niveau de mutations dans la gorge 
des vers, sans toutefois pouvoir confirmer la distribution de APN-1 qui possède 
une étiquette GFP. Les animaux transgéniques APN-1-GFP n’exprimaient pas 
suffisamment de la protéine de fusion pour permettre une visualisation à l’aide 
d’un microscope à fluorescence, mais la protéine a été détectée par 
immunobuvardage de type western. Les animaux transgéniques APN-1-GFP 
étaient instables et avaient des phénotypes concordants avec les défauts 
génétiques. En conclusion, il semble que C. elegans aie évolué afin de retenir un 
niveau de base de APN-1 jouant ainsi un rôle versatile afin de maintenir l’intégrité 
génétique d’autant plus que cet organisme semble manquer plusieurs enzymes de 
la voie de réparation par excision de base. 
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Mots clés : C. elegans, Endo IV, réparation par excision de base, site AP, 
endonucléase de type AP, stress oxidatif, agents causant des dommages à l’ADN, 
réparation de  l’ADN. 
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Abstract 
 
 Apurinic/apyrimidinic (AP) sites are a form of highly mutagenic DNA 
damage that arise either spontaneously or by a variety of DNA damaging agents. 
To preserve genomic stability two AP endonuclease families, endo-IV and exo-III, 
evolved to counteract the mutagenic effect of AP sites. While members of both 
families were identified in multiple unicellular organisms, notably E. coli and S. 
cerevisiae, no members of the endo-IV family were identified in multicellular 
ones, with the exception of C. elegans and its close relatives, particularly C. 
briggsae.  We set out to investigate the biological importance of APN-1 in C. 
elegans using gene knockdown approach. In our study, we showed that the 
knockdown of C. elegans apn-1 gene, using RNAi causes the accumulation of 
spontaneous and drug induced mutations, resulting in a delay in egg hatching, 
decreased survival and longevity. Furthermore, we have showed that the 
accumulated mutations lead to delays in cell cycle progression during early 
embryogenesis, thus providing a possible explanation for the observed delay in 
hatching. Although we showed increased mutations in the gut of the worm, we 
were unable to confirm APN-1 distribution tagged with GFP.  The transgenic 
APN-1-GFP animal did not express enough of this fusion protein to be visualized 
by fluorescent microscopy, although it was detected by Western blot analysis.   
The transgenic animals over-expressing APN-1-GFP were unstable and showed 
phenotypes consistent with genetic defects.  In conclusion, it would seem that C. 
elegans has evolved to retain a balanced level of APN-1, which plays a versatile 
role in maintaining genetic integrity, since this organism lacks a full complement 
of the enzymes in the base-excision repair pathway.  
 
Key words: C. elegans, Endo IV, base excision repair, AP site, AP endonuclease, 
oxidative stress, DNA damaging agents, DNA repair 
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Chapter 1 - Introduction 
1. General Review 
 
 A cell, the main constituent of any living organism, is constantly 
subjected to insults from the surrounding environment as well as from byproducts 
of its own metabolism. These attacks can affect any macromolecule within the 
cell, from proteins and lipids to nucleic acids and may therefore hinder the cell’s 
capacity to grow normally and thrive [1-3]. While damage to lipids and proteins is 
restricted to the affected molecules and their function which can be replaced, 
damage to DNA represents a more widespread disastrous consequence as gene 
mutations may lead to the constant production of aberrant products with 
sometimes no or improper functions. As a result unrepaired DNA damage was 
found to cause apoptosis, cell cycle arrest, permanent mutational changes, and, in 
the worst scenario, a mutation that could lead to the formation of malignant 
tumors; hence the importance of the presence of multiple DNA repair mechanisms 
to ensure genomic stability [4-7]. As such, heritable mutations in multiple DNA 
repair genes have already been associated with cancer-prone phenotypes such is 
the case of xeroderma pigmentosum (XP), cockayne syndrome (CS), ataxia 
telangiectasia (AT) breast cancer 1, early onset (BRCA1) patients among others 
[8-14]. 
 Despite the relatively extensive knowledge that we possess regarding  
DNA repair, more detailed aspects of the pathways that govern this process and 
their inter-connectivity are yet to be discovered, thus the necessity of  studying 
DNA repair and its relation to human syndromes notably cancer and other 
degenerative diseases.  
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2. DNA damage 
 
 In order to further understand the importance of DNA repair and its 
relation to human diseases, it would be essential to understand first the factors that 
contribute to the creation of the wide variety of DNA damages. For this purpose, 
the current section of the introduction is dedicated to discuss in detail the multiple 
sources as well as the types of DNA damages that can occur in the genome of a 
living cell. 
 
2.1. Sources of DNA damage 
 
 The cell’s normal metabolic activity leads to the formation of reactive 
oxygen species (ROS) that are highly reactive due to the presence of unpaired 
valence shell electrons [15].  These small molecules that comprise oxygen ions, 
free radicals as well as peroxides originate primarily from cell respiration during 
electron transport reactions that occur in the mitochondria [15]. ROS molecules 
may also derive from a multitude of other endogenous or exogenous sources such 
as ultra violet (UV) light, ionizing radiation, gamma ray, metal-catalyzed 
reactions, neutrophils and macrophages during inflammation and the atmosphere 
where they are present as pollutants [15].  
 ROS molecules present a beneficial role at low levels where they are 
implicated in cell signaling [15, 16]. It is only when a substantial increase in ROS 
production occurs, such in the conditions mentioned above, that significant 
damage takes place in the cell and jeopardizes its ability to normally grow and 
survive [15]. These conditions are known as oxidative stress and can generate as 
many as 10,000 to 20,000 oxidative DNA lesions/cell/day that include 
apurinic/apyrimidinic (AP) sites and oxidized bases [17]. 
 Other types of endogenously created DNA lesions are those created 
through programmed DNA breaks, such as V(D)J recombination, immunoglobulin 
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class switching and topoisomerase breakage of DNA covalent links for example 
[18, 19].  
 By contrast, multiple exogenous sources can account for DNA damage. 
Of these are multiple human-made chemicals such as methyl methane sulfonate 
(MMS), Radiations (UV, X-rays and gamma rays), viruses and other natural 
factors are also known to directly cause an important amount of DNA damage. 
 
2.2. Types of DNA damage 
 
 The term DNA damage points to any type of aberrant changes to DNA 
integrity and these modifications can occur at any nucleotide or at any position of 
the DNA backbone. As previously discussed, the origin of these damages can be 
highly diverse. The variety of the factors causing DNA damage is the basis of the 
diversity in the type of the modifications observed. Base deamination, 
methylation, and oxidation, AP sites, single strand breaks, double strand breaks 
and inter-strand and intra-strand crosslinks are all examples of damages that can 
occur in the genome of a given cell.  
 
2.2.1. Bulky lesions and inter/intra-strand crosslinks 
 
 Sunlight is composed of 3 main constituents: infrared, visible and ultra-
violet light (UV). UV light is composed of 3 components: UVC (100 nm to 280 
nm), UVB (280 nm to 315 nm) and UVA (315 nm to 400 nm). While UVC is 
largely blocked by the earth’s atmosphere, UVA and UVB have the ability to 
reach the surface of the earth. UVA photons generally increase ROS production 
that in turn causes damage to DNA and other macromolecules. On the other hand, 
UVB photons attack directly biological macromolecules such as the DNA, to 
cause bulky lesions and inter/intra-strand crosslinking [20]. The best known bulky 
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lesions created by the effect of UVB are cis-syn cyclobutane pyrimidine dimers 
and pyrimidine (6-4) –pyrimidone photoproduct, which connect adjacent 
pyrimidine molecules present in the same or different strands of the DNA to create 
a distortion in the DNA structure [21].  
Similarly, since DNA naturally interacts with proteins, UVB was also found to 
induce the formation of DNA-protein crosslinks [20]. 
 
2.2.2. Modification of bases 
 
 In contrast to bulky DNA damages, single base modifications are also a 
well known type of aberrant change in the DNA. In fact, nitrogenous bases can be 
frequently modified by natural endogenous molecules as well as a variety of 
exogenous chemicals. Three main types of modifications are frequently observed: 
base deamination, base oxidation and base alkylation. 
 
2.2.2.1. Deamination 
 
 Deamination is the process of eliminating of the amino group from a 
molecule. In DNA, the bases containing an amino group outside the cyclic 
structure of the base, such as cytosine, adenine and guanine, are susceptible to 
spontaneous deamination. The process of deamination leads to the formation of an 
alternate base that can cause, if unrepaired, multiple types of DNA damage such as 
transversion mutations and base mispairing. For example the deamination of 
cytosine leads to the formation of uracil, which normally is not present in DNA. If 
not removed, uracil has the ability to pair to adenine resulting in GC to AT 
transversion mutation after DNA replication [22]. This mutation constitutes a 
significant source of spontaneous mutations in Escherichia coli (E. coli) [23]. 
Another example is T-G mispairs that arise from the spontaneous deamination of 
methylated cytosine to generate thymine and ammonia [24, 25].  
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 Deamination is not only a spontaneously occurring event; multiple 
factors, such as reactive nitrogen species [26] as well as several proteins such as 
Activation-induced cytidine deaminase (AID) and Apolipoprotein B mRNA 
editing catalytic subunit 1 (APOBEC1) dramatically enhance this process [27, 28].  
 
2.2.2.2. Base oxidation 
 
 Base oxidation can originate from the incorporation of oxidized bases 
present in the nucleotide pool during replication, or it can directly occur at any 
base within the DNA sequence [29]. As mentioned previously, ROS, and more 
precisely hydroxyl radicals, are the main molecules accountable for oxidative 
damage that occurs in normal conditions but that is dramatically increased during 
oxidative stress [15]. Oxidation usually occurs on carbon 5 and 6 of pyrimidines 
and carbon 4 and 8 of purines [30]. Thymine glycol, 8-oxoguanine, 5-formyluracil, 
5-hydroxyuracil and uracil glycol are all examples of oxidized bases [31]. These 
modifications, if not repaired, present a deleterious effect on a living cell as they 
may lead to replication fork arrest which can be lethal, many types of transversion 
mutations that are sometimes associated with cancer, as well as miss-incorporation 
of nucleotides opposite the oxidized bases [15, 29]. Oxidized bases can also be 
removed by DNA glycosylases to create AP sites, which are highly mutagenic as 
they lead to replication fork arrest and when bypassed, can lead to the 
incorporation of an incorrect nucleotide [32]. It is important to mention that 
oxidation can also directly affect the sugar moiety. This generally leads to the 
formation of oxidized AP sites and single strand break formation with 3’-blocking 
groups [33]. 
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2.2.2.3. Base alkylation 
  
 Alkylation is another type of modification that affects DNA bases. As for 
oxidation, alkylation can arise due to the action of endogenous molecules such as 
S-adenosylmethionine (SAM) as well as exogenous sources such as nitrate and 
other man-made drugs, e.g. MMS [34]. The N7-methylguanine (N7-meG) and the 
N3-methyladenine (N3-meA) are the most common endogenously formed alkylated 
bases [34]. These 2 alkylated bases are not directly mutagenic. However, the 
action of DNA glycosylases leads to the formation of AP sites, which in turn are 
mutagenic if not repaired [34]. 
 
2.2.3. Spontaneous base loss 
 
 The N-glycosyl bond linking the base to the sugar phosphate backbone is 
relatively weak and therefore is susceptible to spontaneous hydrolysis that will 
lead to base loss and the formation of AP sites. Even though modified bases 
increase the fragility of the N-glycosyl bond and consequently increase base loss 
and AP site formation, spontaneous base loss still occurs in vivo at a 
physiologically relevant rate [35]. Depurination in E. coli is estimated to occur at 
the rate of 0.5 purine / chromosome / generation [36]. In mammalian cells, it is 
estimated to occur at a frequency ranging from 2,000 to 10,000 purines / 
generation [36]. However, it has been noted that the rate of depyrimidination is 
lower than the rate of depurination [35, 36]. This is due to the double ring structure 
of purines that makes them more susceptible to hydrolysis than pyrimidine.  
 
2.2.4. Single strand breaks 
 
 Similarly to the other types of damages, the hydrolysis of the 
deoxyribose subunit of the DNA backbone to create single strand breaks (SSBs) 
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can result from various exogenous as well as endogenous sources. On one hand, 
the action of free radicals, ionizing radiation and antitumor drugs such as 
bleomycin can directly attack the DNA backbone to create SSBs with 5’-
phosphate and 3’-phosphoglycolate or 3’-phosphate termini [37-39].  
On the other hand, endogenous breakage of the oxidized sugar and abnormal 
activity of cellular enzymes such as DNA topoisomerase 1, account for 
endogenous SSB formation [40]. Moreover, modified bases, such as oxidized or 
alkylated bases, are usually removed by the action of multiple DNA glycosylases 
to create AP sites that can lead to the formation of SSBs through the activity of the 
AP endonucleases or AP lyases [40]. In this case, these SSBs acts as intermediates 
in the base excision repair pathway and thus are not a direct primary damage. 
Whereas AP endonucleases create a single strand break with a 3’-hydroxyl and a 
5’-deoxyribose phosphate termini, AP lyases lead to the formation of 3’-α,β-
unsaturated aldehyde and a 5’-phosphate termini through a β-elimination reaction 
[41]. All these 3’-blocking groups prevent the DNA polymerase from fulfilling its 
role and therefore needs to be processed to recreate the 3’-hydroxyl termini 
normally recognized by the polymerase for the subsequent repair steps. 
  
2.2.5. DNA double strand breaks 
 
Another type of damage that occurs in the DNA can take the form of 
double-strand break (DSB) where both strands of the DNA phosphodiester 
backbone are broken. Like many other types of damages, both endogenous as well 
as exogenous factors account for DSB formation. Replication, recombination, 
meiosis and endogenously produced ROS are all examples of endogenous sources 
while ionizing radiation, UV irradiation and multiple natural or man-made drugs 
are all examples of exogenous sources [42]. It is also important to note that DSBs 
can arise as a result of other damages localized closely in space on complementary 
strands of the DNA molecule. These can be SSB, AP sites or modified bases [43, 
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44]. Regardless of the cause of the DSB formation, these lesions are very 
dangerous as they may lead to chromosomal fusions and genome rearrangement 
[42]. 
 
2.2.6. Result of unrepaired damage 
 
 One of the main processes that should be achieved with high fidelity in 
the cell is DNA replication. On some occasions, the bypass of a modified base or 
an AP site leads to the incorporation of an incorrect base [45, 46]. Usually, cells 
have evolved a proofreading and error-checking mechanism to ensure correct 
replication of DNA [47].  
 However, these replication errors sometimes escape the cell’s 
surveillance systems and create mismatched bases (association of incompatible 
nucleotides). On other occasions, strand misalignments causes small insertions or 
deletions causing a shift in the coding sequence of the gene to create what are 
referred to as frame-shift mutations [48]. 
 
3. DNA repair – Multiple pathways with one aim 
 
 The ultimate goal of any living cell in a multi-cellular organism is to 
ensure that it is fulfilling its role. To be able to do that, any cell has to maintain the 
stability of its genome to avoid the potential devastating effect of DNA damage. 
As briefly discussed previously, there are a multitude of types of DNA damage 
that arise as a result of a variety of endogenous as well as exogenous factors. The 
vast array of DNA damage requires the presence of highly complex mechanisms 
capable of specifically repairing each type of lesion. In fact, cells have evolved 
multiple mechanisms that can be grouped into 5 main pathways that are capable of 
repairing any type of change occurring in the genome as a result of an insult. 
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These mechanisms are direct reversal, double strand break repair, mismatch repair, 
nucleotide excision repair and the base excision repair.  
 After detection of the damage, multiple signaling pathways are triggered, 
leading to an appropriate cellular response [49]. The activation of cell cycle 
checkpoints causes a cell cycle arrest allowing time for the cell to repair the 
damage [49, 50]. At this point, the choice of the DNA repair pathway largely 
depends on the type of the damage encountered. However, some types of DNA 
damages can be repaired through multiple repair pathways, which ensure 
alternatives for the cell to perform the appropriate corrections [51]. 
 Although DNA repair is usually the best option for the cell, the extent of 
the damage can sometimes be large enough to force the cell into an irreversible 
state of dormancy (senescence) or programmed cell death (apoptosis) [4, 49, 52]. 
One should also keep in mind that in certain conditions, the cell is able to bypass 
some lesions that usually stall replication, through the use of alternate polymerases 
that are error-prone and may incorporate wrong nucleotides opposite to the site of 
damage. The bypass of lesions is termed as damage tolerance [45, 46]. 
 
3.1. Double strand break repair 
 
 As previously described, DSB is a lesion in which two breaks on 
opposite DNA strands occurs. This type of damage is particularly hazardous as it 
can lead to a loss of information as well as genomic rearrangement which can be 
lethal [42]. Two distinct repair pathways exist to repair this kind of lesions: 
homologous recombination (HR) and non-homologous end joining (NHEJ) [42].  
 During HR, and after the occurrence of the DSB, a resection of the two 
strands of DNA occurs at the 5’-side of the break to generate 3’-overhangs. One of 
the two single stranded overhangs then invades the homologous chromosome. This 
allows the DNA polymerase to copy the information from the homologous 
chromosome to fill the gap and thus preserve fidelity during repair. The contact 
point between the DNA strands of the 2 chromosomes form what are called 
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holiday junctions that should be resolved to recreate the normal dsDNA. The way 
this junction is cut determines whether a crossover occurs or not [53]. 
 As opposed to HR, the NHEJ pathway is error-prone as it directly connects 
separated mismatched or damaged DNA ends without the use of the homologous 
chromosome [54]. It is important to note here that the choice between the two sub 
pathways depends on the cell cycle stage and is regulated at the resection step [53, 
55].  
 
3.2. Mismatch repair 
 
 The DNA mismatch repair pathway is a conserved mechanism that 
allows the recognition and repair of mismatched bases as well as some insertions 
and deletions that occur during DNA replication or recombination [56, 57]. Since 
the above mentioned damages occur in the newly produced strand during DNA 
synthesis, the cell distinguishes first, in a process that is not yet very well 
understood, between the newly synthesized strand and the template strand. After 
damage and strand recognition, an incision is created that can be up to thousands 
of base pairs away from the site of damage. The resulting nicked strand is then 
degraded, the created gap is filled with the correct nucleotides and the process 
finalized by ligation [57, 58]. 
 
3.3. Nucleotide excision repair (NER) 
 
 Multiple forms of DNA damage lead to a distortion in the helical 
structure of the DNA such as thymine dimers and 6-4-photoproducts caused by 
multiple chemical drugs and UV radiation [20, 21]. These types of lesions are 
processed by the NER pathway through 4 main steps. The process starts with 
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lesion recognition that is followed by removal of the lesion along with a few 
nucleotides to create a small single stranded gap [59].  
 Within NER, one can distinguish two distinct sub-pathways that have 
been very well characterized: transcription coupled repair (TC-NER) and global 
genomic repair (GG-NER). TC-NER is activated when the RNA polymerase stalls 
as a result of a lesion. TC-NER is therefore associated with transcriptionally active 
genes while global genomic repair permits the repair of genes in regions of the 
genome that are not actively transcribed or the non-transcribed strands of 
transcribed regions[60]. These sub-pathways differ by the method of lesion 
recognition but share the same steps of damage processing [59]. NER is a 
particularly important DNA repair pathway as its inactivation is associated with 
multiple human diseases such as XP and CS [59]. 
 
3.4. Direct reversal 
 
 Direct reversal is considered to be the simplest pathway to repair 
damaged DNA as it encompasses a single step, does not require a template and 
does not involve any phosphodiester breakage. Another factor of simplicity is the 
low number of enzymes identified so far that are directly able to reverse lesions. 
Thymine dimers, methylated guanine as well as certain methylation of cytosines 
and adenines are all known to be directly reverted by the cell to their original state. 
In this context, the UV-induced abnormal bonding between adjacent thymine to 
form thymine dimers can be reversed through a photoreactivation process that 
involves an enzyme called photolyase of which the activation depends on exposure 
to UV light [61]. It is important to note though that humans do not possess 
photolyases and thus rely on other repair pathways, such as the NER pathway, to 
repair these types of lesions [61]. Likewise, methylated guanine can also be 
directly reversed to its original state by the enzyme methyl guanine methyl 
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transferase (MGMT) [62]. In the same way, methyladenine and methylcytosine 
were found to be reversed in E. coli through the action of AlkB [62, 63]. 
 
3.5. Base excision repair pathway 
 
 The base excision repair (BER) pathway is a vital and a highly conserved 
mechanism that allows the processing of a variety of non helix-distorting DNA 
lesions. These comprise deaminated, oxidized or alkylated bases, AP sites and 
SSBs with 3’-blocked termini [64, 65]. The repair of these lesions occurs through 
a sequential process involving a set of highly conserved enzymes.  
 The first step of this pathway involves the recognition and processing of 
a modified base, which is generally done through the activity of one of several 
DNA glycosylases [64]. DNA glycosylases can be divided into two groups: mono-
functional and bi-functional glycosylases [66]. While the former is restricted to the 
removal of modified bases through hydrolysis of the N-glycosyl bond linking the 
base to the sugar, the latter is endowed with an additional AP lyase activity [66, 
67]. This activity allows the direct processing of AP sites through a β-elimination 
reaction to generate single strand breaks with 3’-unsaturated aldehyde and 5’-
phosphate termini [41].  Although these enzymes have certain substrate specificity, 
the recognition of multiple lesions by the same glycosylase, or the same lesion by 
multiple glycosylases still occurs, thus providing alternatives to repair damage 
[68]. However, despite the diversity of the substrates and their corresponding 
glycosylases, the resulting base removal induces the formation of an AP site.  
 The second step of the pathway involves an AP lyase as described 
above, a delta lyase or an AP endonuclease, all with the ability to process AP sites. 
While delta lyases create an incision at AP sites and process 3’-aldehyde to create 
3’-phosphate termini, AP endonuclease enzymes incise DNA backbone at the 5’-
side of AP sites to generate 3’-hydroxyl and 5’-deoxyribosephosphate (dRP) 
termini [41]. AP endonuclease also possesses a 3’-diesterase activity allowing the 
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removal of 3’-blocking groups such as those left by AP lyase and delta lyases [41]. 
It is essential to create the hydroxyl group at the 3’-terminus of the DNA break as 
it serves as a primer for DNA polymerase for the subsequent steps of the pathway. 
At this point, the pathway can diverge into either short patch (SP) or long patch 
(LP) BER.  
 During SP repair, the 5’-dRP is removed by the action of a dRP lyase, 
resulting in the formation of a 5’-phosphate terminus. The removal of the 5’-dRP 
is followed by the incorporation of a single nucleotide by DNA polymerase, using 
the 3’-OH as a primer, to fill the created gap. Finally, the DNA ligase comes into 
play to reconnect the separated DNA fragments [69].  
 During LP repair, modified AP sites (e.g. oxidized) lead to the formation 
of modified dRPs which cannot be removed by the dRP lyase activity. As a result, 
multiple nucleotides are incorporated at the 3’-side of the damage leading to the 
displacement of the strand containing the 5’-dRP, thus creating a flap, which is 
then removed to create a 5’-phosphate terminus. Finally, the presence of 5’-
phosphate and 3’-OH termini is essential for efficient ligation by DNA ligase that 
will reconnect the separated DNA fragments [69]. 
 
4. AP endonucleases/3’-diesterases 
 
 The frequent occurrence of AP sites necessitates efficient processing as 
they are highly mutagenic. The AP endonucleases and the AP lyases are two 
classes of enzymes with the ability to process AP sites. The incision made by AP 
lyase lead to the formation of blocked 3’-ends which need 3’-diesterase activity to 
be removed, whereas the ends created by AP endonuclease (i.e. 3’-hydroxyl and 
5’-deoxyribose phosphates) can be directly used by dRP lyase and polymerase for 
the following steps of BER [41]. In addition, AP endonuclease enzymes possess a 
3’-diesterase activity allowing them to process 3’-blocking groups left by AP 
lyase. Thus, AP endonucleases are considered to be far more important then AP 
lyases in processing AP sites [41]. This has also been supported by findings 
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showing that endonuclease deficient yeast strains are more sensitive to MMS, but 
not AP lyase deficient yeast strains [70, 71].   
To date, two families of AP endonucleases / 3’-diesterases, termed Endo IV and 
Exo III after the ancestral bacterial enzymes, have been well characterized [41]. 
Multiple studies led to the identification of members of the Exo III family in many 
organisms both unicellular and multicellular (prokaryotes and eukaryotes). In 
contrast, members of the Endo IV family were only found in unicellular organisms 
with the exception of Caenorhabditis elegans (C. elegans). Most of these enzymes 
possess, in addition to the AP endonuclease and 3’-diesterase activities, 3’- to 5’- 
exonuclease and RNase H activities [72].  
Despite the presence of a certain degree of redundancy between the two families, 
as shown in multiple studies of cross-species complementation, some differences 
regarding levels of expression and substrate specificity do exist [41]. However, the 
key feature used to differentiate between the two families is their magnesium 
dependency. While members of the Endo IV family are Mg2+ independent (EDTA 
resistant), it was shown that Exo III family members are magnesium dependent 
and therefore EDTA sensitive [41].  
 Since this project investigates the in vivo characteristics of the Endo IV 
family member in C. elegans, the current section of the introduction will address 
the present state of knowledge regarding AP endonucleases / 3’-diesterases in E. 
coli, Saccharomyces cerevisiae (S. cerevisiae), humans and C. elegans with 
special attention accorded to Endo IV family members.  
 
4.1. AP endonuclease/3’-diesterase enzymes in E. coli 
 
 The first indication regarding the presence of a specific class of enzymes 
capable of processing AP sites came from studies in E. coli. These studies showed 
that an enzyme, first described as a 3’→ 5’ exonuclease with a 3’-phosphatase 
activity (named exonuclease III), also possess an endonuclease activity capable of 
generating single strand breaks through the hydrolysis of the phosphodiester bonds 
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of alkylated bases [73-76]. At this time, the second activity was thought to be 
generated from a different enzyme then exonuclease III, that was named 
endonuclease II [73, 74]. Later, it was found that the same mutation commonly 
disrupts exonuclease III and endonuclease II activities [77]. It wasn’t until 1976 
that these enzymatic activities were attributed to the same enzyme. This discovery 
occured when it was found that the purification of exonuclease III always resulted 
in the co-purification of endonuclease II activity [78]. Moreover, denaturing 
polyacrylamide gel using the purified exonuclease III always showed a single band 
suggesting that one protein is responsible for both activities [78].  
The hunt for the second AP endonuclease enzyme was initiated by the finding that 
exonuclease III mutants still possess a low AP endonuclease activity (~10%) [79, 
80]. The endonuclease IV was isolated from crude extracts deriving from E. coli 
mutants lacking the exonuclease III enzyme.  
 
4.1.1. Characteristics of E. coli exonuclease III 
 
Exonuclease III is the major AP endonuclease enzyme in E. coli as it 
accounts for 90% of the total AP endonuclease activity. It is encoded by the xth 
gene, and is predicted to produce a ~31 kDa protein [81]. It has been shown that 
exonuclease III requires magnesium for its activity and therefore is EDTA 
sensitive [41]. Moreover, exonuclease III was found to be heat sensitive as it 
degrades rapidly upon incubation of the purified protein at moderately high 
temperatures [79, 80]. Studies of this enzyme established that it possesses 4 
different catalytic activities. It is a 3’ to 5’ exonuclease with an activity specific for 
dsDNA allowing it to degrade blunt ends, 5’-overhangs or nicks to produce 
segments of ssDNA [72]. However, this activity was not observed on 3’-overhangs 
that are over 4 bases long similarly to what is observed on ssDNA [72]. 
Exonuclease III is also a phosphatase allowing the removal of 3’phosphate to 
generate a 3’-OH terminus and an RNase H that allows the degradation of RNA in 
DNA-RNA hybrids [72]. Finally, and most importantly, exonuclease III is an 
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apurinic/apyrimidinic endonuclease that has the ability to nick phosphodiester 
bond at AP sites as a step in BER [72]. 
  
4.1.2. Characteristics of E. coli endonuclease IV 
 
 The endonuclease IV, product of the E. coli nfo gene, is a predicted 31 
kDa protein that was discovered as a second and minor AP endonuclease enzyme 
in E. coli. Multiple studies have shown that this enzyme can incise the 
phosphodiester bond at 5’ of AP sites and certain oxidized nucleotides (Nucleotide 
incision repair pathway NIR), but not other types of damages (e.g. bulky lesions), 
to create single strand breaks with 3’-OH terminus that is involved in subsequent 
steps of the BER pathway [79]. In addition, this enzyme was found to possess a 3’-
diesterase activity allowing it to remove 3’-blocking groups at single strand breaks 
such as those resulting from the activity of AP lyase [82]. In recent studies, it was 
discovered that purified endonuclease IV also possess a 3’→5’ exonuclease 
activity with a preference for 3’-recessed ends of dsDNA [83]. By contrast to the 
AP endonuclease and 3’-diesterase activities, the 3’→5’ exonuclease activity was 
found to be inhibited in the presence of the metal chelator EDTA and reducing 
conditions [83]. 
As mentioned earlier, endonuclease IV is considered to be the minor AP 
endonuclease in E. coli and it was found to constitute 10% of the total AP 
endonuclease activity in bacterial cells [80]. However, it was demonstrated that 
this enzyme can be induced as much as 20-fold by superoxide anion generators 
such as paraquat [84]. As such, the level of endonuclease IV becomes comparable 
to that of exonuclease III [84] but its 3’-diesterase activity always remains lower 
than that of exonuclease III [85].  
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4.1.3. Importance of the AP endonuclease/3’-diesterase 
enzymes in E. coli– mutational analysis 
 
 The in vivo relevance of AP endonuclease/3’-diesterase enzymes in E. 
coli was investigated using mutants defective in either of the two families or both. 
These studies revealed an important degree of overlap between the two families 
[86]. Studies of the xth mutant, lacking the major AP endonuclease, was found to 
be very sensitive to MMS [77] whereas the nfo mutant, lacking the minor AP 
endonuclease, seems only slightly sensitive to the same drug [86]. These 
observations are consistent with the expression level of each family, allowing 
exonuclease III to highly complement the absence of endonuclease IV. The DNA 
damaging agent MMS mainly alkylates purines by methylating guanine at position 
N-7 and adenine at position N-3, among others [87, 88]. Another type of DNA 
damaging agent to which the xth mutant is sensitive to is hydrogen peroxide 
(H2O2). This oxidant causes base oxidation as well as single strand breaks with 3’-
blocked termini which cannot be processed by  DNA polymerases since they 
require a 3’-OH terminus to initiate DNA repair synthesis [89, 90]. By contrast, 
the nfo mutant shows no apparent sensitivity to H2O2 [86].  
 The fact that the double knockout xth nfo shows a higher sensitivity to 
the above-mentioned DNA damaging agents suggests that endonuclease IV acts in 
vivo as a backup enzyme in conditions of stress [86]. However, certain studies 
have demonstrated that the overlapping function of the two enzymes is not entirely 
accurate. In fact, it was found that some lesions repaired by endonuclease IV are 
not processed by exonuclease III. This was illustrated by the fact that the nfo 
mutant shows a very high sensitivity to the DNA damaging agent bleomycin 
(BLM) as well as tert-butyl hydroperoxide (t-BH) whereas the xth mutant seems 
only slightly affected by t-BH and not at all by BLM [86]. Furthermore, the double 
mutant xth nfo did not show any apparent increase in sensitivity to either of the 
two DNA damaging agents when compared to the single mutants [86]. BLM is an 
anti-tumor drug known to produce oxidized AP sites, single strand breaks with 3’-
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blocked ends as well as double strand breaks [91], while t-BH is an oxidant of 
which the resulting DNA damage is not very well understood.  
Furthermore, endonuclease IV but not exonuclease III was found to directly incise 
at the 5’-side of various oxidized bases, independently of DNA glycosylases, to 
create 3’-hydroxyl and 5’-phosphate termini, in the NIR pathway [92]. 
 
4.2. AP endonuclease/3’-diesterase enzymes in S. 
cerevisiae 
 
 Shortly after the discovery of AP endonuclease enzymes in E. coli, 
evidence of the presence of their homologues came to light in the first eukaryotic 
organism, S. cerevisiae. These enzymes, Apn1 and Apn2, were found to have 
similar characteristics to their homologues in E. coli, endonuclease IV and 
exonuclease III, respectively. However, some differences are still noticeable.   
 
4.2.1. Characteristics of S. cerevisiae Apn1 
 
 The discovery of AP endonuclease enzymes in E. coli initiated efforts to 
find their homologues in higher organisms. The first hint of the presence of these 
enzymes in yeast cells came in 1978, when three AP endonuclease activities were 
partially purified by Paul R. Armel and Susan S. Wallace [93]. However, the 
actual major AP endonuclease enzyme in yeast was only purified and partially 
characterized in 1988 [94, 95].This 40.5 kDa monomer metalloenzyme was found 
to share significant amino-acid identity with its E .coli homologue, endonuclease 
IV, and was found to possess a similar zinc cluster in the active site [94, 96]. 
A couple of years later, the APN1 gene encoding the major yeast AP endonuclease 
enzyme was identified [97]. Disruption studies of this gene confirmed that its 
protein product accounts for 97% of the total cellular AP endonuclease as well as 
3’-diesterase activities [97]. Further studies confirmed that, similar to its E. coli 
counterpart, the Apn1 protein possess a 3’→5’ exonuclease activity on duplex 
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DNA with preference for 3’-recessed DNA ends [98]. This activity was shown to 
permit the removal of 8-oxo-7,8-dihydrodeoxyguanosine (8oxoG) resulting from 
either the misincorporation of 8oxoGTP by DNA polymerase or the direct 
oxidation of guanines [98]. Although the processing of the 8oxoG lesions mainly 
occurs through the activity of 8-oxo-dGuo DNA glycosylase, OGG1 [99], the 
3’→5’ exonuclease activity of Apn1 was found to constitute an alternative 
pathway for the repair of such lesions. Actually, the knockout of both ogg1 and 
apn1 was found to increase the rate of spontaneous mutations. These mutations are 
mainly due to G.C to T.A transversions which are normally observed in the Ogg1 
single mutant [98]. Furthermore, Apn1 was shown to take part in the NIR pathway 
[100]. Similarly to E. coli endonuclease IV, Apn1 was not found to require 
magnesium for its activity and thus is EDTA resistant [41]. 
 The study of the structure of the Apn1 protein revealed the presence of a 
long C-terminal region rich in basic amino acids that is not present in its E. coli 
homologue endonuclease IV [97]. This extension contains two main 
lysine/arginine clusters that serve as a nuclear localization signal (NLS) [101]. 
Removal of cluster one was not found to affect the enzyme’s stability and activity 
as this protein was still able to complement AP endonuclease deficient E. coli; 
instead it abolished its nuclear localization. Furthermore, the replacement of 
cluster 1 with the simian virus 40 (SV40) NLS was also associated with defective 
nuclear localization indicating the presence of highly specific transport machinery 
for the transport of Apn1. In fact, the C-terminal region was found to act as a 
bipartite NLS as neither cluster 1 nor cluster 2 alone can target the protein to the 
nucleus [101].  
 In addition to its role in the nuclear localization of the protein, the C-
terminal region was also found to target the enzyme to the mitochondria through 
its interaction with Pir1, a previously identified cell wall protein. The absence of 
Pir1 was found to correlate with an accumulation of the protein in the nucleus and 
the cytoplasm and a parallel reduced level of Apn1 in the mitochondria [102]. 
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 Other structural studies pointed out two conserved amino acids (Glu 158 
and Asp 192) the substitution of which disrupts the biological function of the 
protein, suggesting that these amino acids might constitute the actual active site 
[103]. 
 
4.2.2. Characteristics of S. cerevisiae Apn2 
 
 The fact that apn1 knockout (Δ) yeast cells respond similarly to wild type 
yeast cells to certain DNA  damaging agents such as BLM, raised the question of 
whether another enzyme was present to counter this type of lesions [104]. The 
effort of two independent groups led to the simultaneous identification of the Apn2 
protein, the homologue of E. coli exonuclease III [88, 105]. By contrast to its 
homologue in E. coli, the Apn2 protein was found to possess AP endonuclease, 3’-
diesterase and 3’→5’ exonuclease activities that do not require magnesium and 
that are maintained even after 24 hours of incubation with EDTA [70]. The 
transcription of the gene was found to be induced up to six-fold by treatment with 
MMS [105] and its 3’-diesterase and 3’→5’ exonuclease activities stimulated by 
proliferating cell nuclear antigen (PCNA) [106].  
 Structural studies revealed the presence of a large C-terminal extension 
that is not present in exonuclease III [105]. When deleted, the resulting truncated 
protein was found to retain its AP endonuclease activity in vitro but severely lack 
the ability to complement the AP endonuclease deficiency of the apn1 apn2 double 
mutant cells in vivo [70] suggesting that this portion of the protein might be 
responsible for the proper localization of the protein. 
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4.2.3. Importance of AP endonuclease/3’-diesterase 
enzymes in S. cerevisiae – mutational analysis 
 
 A mutational analysis revealed the major role of Apn1 in the BER 
pathway as compared to the lesser role of Apn2. In fact, the deletion of apn1 was 
found to increase 6- to12-fold the rate of spontaneous mutations in the cell, in 
contrast to apn2 where no increase was detected [104]. Furthermore, treatment of 
the apn1 mutant with DNA damaging agents such as MMS, H2O2 and t-BH, 
revealed an accumulation of DNA lesions that correlated with a hypersensitivity to 
the mentioned drugs [70, 104]. However, similar investigations using the apn2 
mutant however, did not reveal any increased sensitivity [70, 105]. Interestingly, 
the apn1 apn2 double mutant was found to be even more sensitive than the apn1 
single mutant to the same DNA damaging agents [70]. These results point to the 
fact that Apn1 provides the main AP endonuclease activity in the cell whereas 
Apn2 seems to be acting as a backup enzyme for Apn1. The study of the response 
of these mutants to BLM revealed that only the double mutant, but none of the 
single mutants, is sensitive to the drug, reflecting the inability of any of the two 
enzymes alone to process the damages created by the action of BLM [104, 105]. 
 
4.3. AP endonuclease/3’-diesterase enzymes in humans 
 
 Similarly to other organisms, human cells were found to contain AP 
endonuclease enzymes. However, the proteins found in human cells, APE1 and 
APE2, both belong to the Exo III family. To date, no homologues of the Endo IV 
family of the AP endonucleases/3’-diesterases have been identified in human cells.  
 
4.3.1. General characteristics of human APE1 
 
 The human AP endonuclease enzyme, APE1, was purified for the first 
time from HeLa cells [107] and later cloned and sequenced from cDNA expression 
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libraries obtained from human placenta and melanoma cells [108, 109]. The APE1 
gene was found to encode a 318 amino acid protein with a molecular weight of 37 
kDa [108, 109].  
 Functional analysis revealed that the enzyme, similarly to E. coli 
exonuclease III, possesses a strong AP endonuclease activity [110]. However, 
unlike the other Exo III family members, the 3’-diesterase activity of APE1 was 
found to be relatively weak [110-112]. Many studies of the 3’→5’ exonuclease 
activity of APE1 led to multiple publications with conflicting results. While some 
found that APE1 presented no exonuclease activity against blunt ended dsDNA 
[110, 113], others demonstrated that this exonuclease activity was structure 
specific and presented a preference for 3’-mismatched nucleotides [114-116]. The 
fact that this exonuclease activity processes only one to two nucleotides on duplex 
DNA suggests that this function might be providing a proofreading role to 
compensate the absence of proofreading by the error-prone polymerase β [116-
118]. Additionally, RNase H activity has been also associated with APE1 [113, 
119]. 
 While the APE1 enzyme has been found to possess a strong affinity for 
AP sites and thus requires no magnesium to bind the DNA substrate, Mg2+ was 
found to be essential for the enzymatic activities of the protein as well as for its 
dissociation form the incised AP sites [120]. 
 Mutational analysis revealed the presence of a common catalytic site for 
the different DNA repair activities of the protein, as the same substitution was 
found to alter all of these activities [113, 121]. Specific amino acid substitutions 
revealed the function of multiple key amino acid residues in the protein. While Glu 
95 was established to be implicated in metal binding [113, 121-123], Asn 212 and 
Asp 219 were found to be implicated in AP site recognition and binding [113, 
124]. Moreover, Asp 210 was found to be responsible for phosphodiester bond 
cleavage and separation of APE1 from the DNA substrate [125]. The His 309 
residue was found to likely be the catalytic residue of the protein as its mutation 
leads to a reduction of all of the activities of the enzyme [121] 
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 In addition to its direct role in DNA repair, APE1 was found to 
coordinate the whole BER pathway in human cells. In fact, it has been shown that 
APE1 interacts with multiple DNA glycosylases to stimulate their binding to DNA 
(i.e. adenine DNA glycosylase hMYH) [126] or to promote their dissociation from 
DNA (i.e. TDG, Ogg1…) [127-129]. Furthermore, studies have demonstrated the 
physical interaction of APE1 with DNA polymerase β, facilitating its access to AP 
sites and accelerating the removal of 5’-dRP resulting from the incised AP site 
[130]. APE1 was also found to interact with FEN1, PCNA and DNA ligase I, and 
to stimulate their activity [131, 132].  
 Very interestingly, APE1 was also found to be implicated in other 
processes that are not directly related to DNA repair. As such, it has been shown 
that APE1 is a redox factor and can activate and stimulate the binding of a number 
of transcription factors to DNA [133-135]. A mutational analysis identified Cys 65 
as the redox active site of the protein [136].  
 While APE1 shares no sequence identity with Apn1 or endo IV, it was 
found to possess NIR activity, indicating that this enzyme has evolve with a broad 
substrate specificity and may compensate for the lack of endo IV-like enzyme in 
human cells [137]. 
 
4.3.2. General characteristics of human APE2 
 
 The second AP endonuclease enzyme identified in humans, APE2, is a 
518 amino acid protein with a calculated molecular weight of 57.3 kDa [138]. This 
enzyme was found to possess a weak AP endonuclease activity that is about seven 
fold higher than its 3’-diesterase activity [110]. Structural studies revealed the 
absence of the redox domain that is present in APE1 [138]. However, APE2 was 
found to possess a long C-terminal domain that was shown to contain a PCNA 
binding motif, similar to the one present in S. cerevisiae Apn2, suggesting a 
possible role in LB BER [139]. Multiple reports also suggested a possible role for 
the C-terminal domain of APE2 in localizing the protein to the nucleus [138].  
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Interestingly, in addition to its nuclear localization, APE2 was found to be 
localized to the mitochondria through a potential mitochondrial localization signal 
in its N-terminal portion, suggesting a possible role in the maintenance of the 
mitochondrial DNA’s integrity [139]. 
 
4.3.3. The importance of the BER and the AP 
endonuclease enzymes in mammalian cells 
  
 As is the case in different biological processes, BER can be compromised 
at the level of its operating enzymes. In fact, it has been shown that mutations in 
multiple genes of this pathway, including AP endonucleases / 3’-diesterases, can 
be associated with many human diseases such as neurodegenerative disorders and 
cancer [140-143]. Additional reasons fueling our interest in further studying the 
families of AP endonucleases / 3’-diesterases came from multiple observations 
that AP endonuclease knockout mice were found to be embryonic lethal and the 
knockdown of in vitro human cancer cell lines were found to arrest cell 
proliferation and activate  apoptosis [144, 145]. 
 
5. Caenorhabditis elegans 
 
5.1. General information 
 
 C. elegans is a free-living animal that is normally present in the soil and 
other bacteria-rich environments. It is a multi-cellular organism of the nematode 
phylum that has been very widely used in research since 1974 [146]. Multiple 
studies led to the portrayal of the complete cell lineage as well as the complete 
description of the anatomy of the whole animal [147]. The adult worm contains 
1000 somatic cells, possesses a mouth, a pharynx, an intestine, a gonad, an 
excretory system, muscles an epithelial system and a cuticle made of collagen 
(wormatlas). It is also known to be the simplest animal with a central nervous 
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system [148]. In nature, one can find self-fertilizing hermaphrodites and males but 
no females [149]. The sexual organs differ between males and hermaphrodites as 
males have a single lobed gonade, a ductus deferens and a copulatory apparatus in 
the tail for mating while hermaphrodites, on the other hand, have two gonades, 
oviducts, a spermatheca, and a single uterus (wormatlas).  
 The reason behind the success of using C. elegans in research comes 
from the fact that it is easy to manipulate and can be easily grown for low cost in 
the laboratory on the bacterium E. coli [149]. It has a relatively short life span and 
can survive freezing for many years, which allows long-time storage of multiple 
strains. This organism is also transparent, allowing easy visualization of internal 
development and organs, as well as easy visualization of fluorescently tagged 
proteins and different types of staining [149]. Another strong point in the favor of 
the use of C. elegans in research is the relatively small genome in a small yet 
relatively complex metazoan. In fact, C. elegans was the first multi-cellular 
organism to have its genome sequenced and published in 1998 [150], with the last 
gap sequenced and published in 2002. The 100 million base pair genome contains 
an approximate 20, 000 genes that are represented on five pairs of autosomes and 
one pair of sexual chromosomes. The sexual orientation of the offspring is based 
on the XO sex-determination system, where XX signifies hermaphrodites and XO 
represents the rare males. Males are infrequently produced (0.1%) by spontaneous 
meiotic non disjunction in the hermaphrodites where one of the daughter cells 
inherits 2 X chromosomes while the other inherits none [151]. The production 
frequency of males increases by up to 50% upon introduction of males into a 
hermaphrodite population as male sperm preferentially fecund oocytes [149]. The 
complexity of this animal is exemplified by a diversity of intricate behavior 
including locomotion, foraging, feeding, defecation, egg laying, dauer larva 
formation, sensory response to touch, smell, taste, temperature, male mating, 
social behavior, learning and memory [152-156]. 
 All the above mentioned characteristics render this organism a model of 
choice in multiple studies related to cellular processes such as cell fate 
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determination and differentiation as well as apoptosis. Genomics, aging and 
multiple studies concerning human nervous-based diseases such as Alzheimers 
and Parkinsons also used C. elegans as a model organism [157-160]. 
 Similarly, this organism provides a big advantage to study DNA repair 
then yeast and bacterial cells do. This is mainly due to the complex behavior that 
this model possess, notably, egg hatching, speed of growth and individual survival, 
that can be studied upon a loss of a DNA repair protein and which cannot be 
assessed in other simpler organisms such as yeast and bacterial cells. 
 
5.2. Life cycle 
 
 The C. elegans life cycle comprises six stages of development, starting 
with embryonic development that occurs in part inside the hermaphrodite, while 
the second part takes place in the outside environment in the form of laid eggs 
[149]. Each egg gives rise to an L1 larva which then develops quickly through a 
series of four molts passing from L1 to adult [149]. Under starvation conditions 
and overcrowding, the L2 larva can enter an alternative 3rd stage called the dauer 
larva that is characterized by a thick cuticle, a sealed mouth and a very low 
metabolism, allowing it to survive for months under these conditions, whereas all 
the adult worms die off. The dauers resume development by entering the L4 stage 
upon re-introduction to a food source [149]. 
 Since C. elegans is a cold-blooded animal, the temperature of the 
environment largely influences the speed of development and the time intervals 
between the molts. Incubation temperatures usually used in the laboratory are 16, 
20 and 25˚C, where 16˚C allows the slowest growth rate and 25˚C, the fastest. In 
fact, it was found that growth at 25˚C is 2.1 times faster than it is at 16˚C and 1.3 
times faster than it is at 20˚C [149]. Incubation of plates at lower temperatures, 
such as 6-8˚C, result in growth arrest and can be used to temporarily arrest 
development for up to 15 hours [149]. The incubation temperature also affects the 
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overall longevity of the worm as C. elegans live longer at lower temperatures than 
in warmer environments. 
 
5.3. RNA interference in C. elegans 
 
 Gene silencing through RNA interference (RNAi) has lately become an 
important tool to study gene function through analysis of the consequences of the 
decrease of its expression. However, prior to the detailed characterization of the 
technology, mis-conceptions and confusion regarding RNAi existed in the 
scientific community.  
 Early observations linking RNA molecules to gene silencing came in the 
early 1980’s, when small RNA molecules (~100 nucleotides) in E. coli were found 
to bind complementary mRNAs and inhibit their translation [161]. This same 
translation regulation was also found to occur in eukaryotes, such as C. elegans 
[162-166], among others [167]. In early experiments, anti-sense RNA [168] and, 
surprisingly, sense RNA [99, 169] were both found to lead to gene silencing. 
Later, experiments conducted by Fire and Mello revealed that only the injection of 
double-stranded RNA (dsRNA), and not antisense nor sense RNA alone could lead 
to efficient gene silencing [170]. The earlier studies showing an effect with either 
sense or antisense RNA were explained by the fact that the RNA preparations 
were probably not totally pure and contained a small amount of dsRNA [171]. 
Within this study, Fire and Mello demonstrated that the observed gene silencing 
was specific for the mRNA homologous to the injected dsRNA [172].  The 
sequence of the dsRNA should correspond to that of the mature mRNA and not 
introns or promoter sequences, indicating that the silencing observed is post-
transcriptional [172]. It was also shown that the targeted mRNA was degraded and 
only a few dsRNA molecules were sufficient to fully silence a given gene. More 
importantly, the silencing effect was found to spread from one cell to another and 
was found to be transmitted to the progeny [170].  
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 Further characterization of the RNAi mechanism showed that the long 
dsRNA is first cut into short pieces (~25 nucleotides long) by a ribonuclease III-
like nuclease named Dicer [173]. The short antisense strand is then loaded into a 
large complex called RISC (RNA-induced silencing complex), that is targeted to 
cleave the mRNA through the antisense small interfering RNA (siRNA) [174]. In 
fact, the RISC complex was found to contain a protein from the argonaute family 
that is thought to act as an endonuclease to cleave the mRNA [174]. Interestingly, 
the RNAi mechanism was found to be amplified in certain organisms such as 
worms and fungi, through the action of an RNA-dependent RNA polymerase 
(RdRP) that generates and/or amplifies siRNA [175].  
 In C. elegans, RNAi technique has been widely used to study gene 
function. Multiple techniques were tested in order to deliver the dsRNA that is 
essential for the knockdown of gene expression. These include injecting the 
dsRNA into the worm, soaking the worms in a solution containing the dsRNA or 
feeding the worms bacteria genetically designed to express the dsRNA of the 
targeted gene. 
 
5.4. AP endonuclease/3’-diesterase enzymes in C. elegans 
 
 Early discoveries of AP endonuclease enzymes indicated the presence of 
two families, Endo IV and Exo III, in unicellular organisms whereas only 
members of the Exo III family were identified in multicellular beings. This reality 
soon changed with the identification of both families in the first multi-cellular 
organism, C. elegans. However, to date, very little is known about the in vivo 
characteristics of these DNA repair enzymes. 
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5.4.1. Known characteristics of C. elegans apn-1 and 
Ceexo-III 
 
 Previous studies in E. coli and S. cerevisiae have demonstrated the 
importance of the Endo IV and Exo III family members in repairing AP sites and 
single strand breaks with 3’-blocked termini. These characteristics led to the 
assumption that proteins of these families might be conserved in higher organisms. 
The high homology seen between E. coli endonuclease IV and S. cerevisiae Apn1 
was used to isolate the cDNA of the C. elegans apn-1 gene using a λ phage cDNA 
library prepared from C. elegans [176]. The isolated cDNA was expected to 
encode a 278 amino acid protein with a calculated molecular weight of 30 kDa. 
Sequence analysis revealed that this protein shares 40.4% identity with ScApn1 
and 44.9% identity with E. coli endonuclease IV [176]. Furthermore, these results 
were reinforced with the finding that crude extracts from C. elegans embryos 
possess AP endonuclease activity [177]. However, it was not sure whether this 
activity belonged to the product of the isolated apn-1 gene or to another AP 
endonuclease enzyme present in this organism. A few years later, cross species 
complementation studies using a C. elegans cDNA library to complement the 
yeast mutant lacking both Apn1 and Apn2 led to the isolation of two genes, apn-1 
and exo-3, encoding the homologues of the Endo IV and Exo III families 
respectively [178]. Similarly to the high level of shared identity found between 
apn-1 and its homologues in S. cerevisiae and E. coli, the exo-3 gene was found to 
share 27% identity with E. coli xth and 45 % identity with H. sapiens Ape1 [178]. 
 Expression of either APN-1 or EXO-3 reduced the spontaneous mutation 
rate exhibited by the yeast apn1 apn2 double mutant. Furthermore, the 
hypersensitivity of this yeast mutant to multiple DNA damaging agents such as 
H2O2 and MMS was alleviated by the introduction of either apn-1 or exo-3. 
However, while complementation using exo-3 restored full resistance to BLM, 
complementation using the apn-1 gene conferred only partial resistance to this 
drug, reflecting a certain degree of substrate recognition specificity between the 
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two enzymes [178]. These observations were supported by in vitro studies, where 
crude extracts from the yeast double mutant, transformed with either apn-1 or exo-
3 were found to contain AP endonuclease activity, reflecting that the product of 
both genes are endowed with this activity [178].  
 Further characterization of C. elegans EXO-3 led to the identification of 
two point mutations, D190A and H279A, which disrupt the AP endonuclease and 
3’-diesterase activities of the protein, revealing the importance of these residues 
for the activity of this enzyme. Another amino acid substitution, E68A, was found 
to retain AP endonuclease and 3’-diesterase activities but severely lack the ability 
to protect the yeast mutant against DNA damaging agents such as MMS, H2O2 and 
BLM. These amino acids correspond to residues E96, D219 and H309 that are 
critical for the function of the human Ape1 enzyme [178]. Additional investigation 
of the role of Glu68 revealed that this amino acid residue is important for the 
binding of Mg2+ to the EXO-3 protein as is the case with its corresponding amino 
acid, Glu96, in the human Ape1 enzyme. Furthermore, the E68 residue of EXO-3 
was found to facilitate the release of the EXO-3 protein from the DNA to allow 
subsequent repair components to complete the pathway [179]. 
It is also important to note that, in contrast to E. coli exonuclease III and S. 
cerevisiae Apn2, C. elegans EXO-3 was found to possess a very low 3’→5’ 
exonuclease activity [178, 179]. 
 
6. Research project and summary of results 
 
 The characterization of AP endonuclease enzymes in many models, 
notably humans, enhanced our understanding of the importance of the BER 
pathway in protecting cells from specific types of DNA damage. The search for 
these enzymes in multiple organisms, led to the identification of the Endo IV 
family in prokaryotes and some eukaryotes, but not in high eukaryotes such as 
humans, whereas the Exo III family was found in all organisms. This suggests a 
probable loss of the Endo IV family function through an evolutionary process. 
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Until the discovery of the C. elegans AP endonuclease enzymes, no members of 
the Endo IV family were identified in multi-cellular organisms, rising questions 
regarding the relevance of this family in C. elegans and providing a tool that might 
explain its absence in higher organisms. We therefore hypothesized that APN-1 is 
important to preserve the genomic integrity of C. elegans.   
 Previous characterization of the C. elegans exo-3 and apn-1 genes 
through cross species complementation demonstrated the presence of AP 
endonuclease and 3’-diesterase activities associated with the products of both 
genes [178]. The C. elegans genes were also found to complement yeast mutants 
deficient in AP endonuclease/3’-diesterase activity, allowing them to counteract 
damages caused by multiple DNA damaging agents such as H2O2 and MMS [178]. 
However, these findings do not totally reflect the in vivo function of these genes as 
the study was performed in a totally different organism than the natural host. 
Furthermore, the system used represents an over-expression system and therefore, 
might lead to an inaccurate assumption of the in vivo role of these enzymes. 
 Thus, we sought to characterize the apn-1 gene in C. elegans. We 
conducted RNAi experiments to decrease the expression of this gene and follow its 
consequences on different aspect of the animal’s life. A transgenic worm, over-
expressing the full length GFP tagged APN-1 protein, was prepared to be used for 
protein localization and the verification of knockdown efficiency. Western blot 
analysis using crude extracts obtained from the transgenic animals demonstrated 
the efficiency of the knockdown system used. Similarly, qRT-PCR studies using 
RNA extracts from the C. elegans parental N2 strains further verified the 
knockdown efficiency in the parental strain. Additional analysis, using the β-
galactosidase reporter assay, revealed elevated mutation levels as a result of apn-1 
knockdown. This was found to correlate with a delay in embryonic development 
and a decrease in the egg hatching percentage. Interestingly, cell cycle studies 
revealed that the delay observed during embryonic development may be partially 
due to the slow progression of the cell cycle that is resulting from the knockdown 
of the apn-1 gene and that is increased by DNA damaging agents.  
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 Surprisingly however, the knockdown of apn-1 was not found to decrease 
the longevity of the worms. Nevertheless, when challenged with DNA damaging 
agents that cause AP sites, (t-BH and MMS), the worms’ lifespan was decreased. 
Our study therefore provides solid evidence that APN-1 can function in vivo to 
maintain the integrity of the genome. 
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Chapter 2 – Materials and methods 
 
1. C. elegans Strains and maintenance of nematode 
cultures 
 
 C. elegans strains Bristol N2 (parent) and NL3400: pkIs1604 [rol-
6(su1006) hsp16/2::ATG(A)17gfp/lacZ (out of frame)] were obtained from the C. 
elegans stock center (University of Minnesota, USA). C. elegans strain expressing 
full length GFP tagged APN-1 protein (APN-1-GFP strain) was prepared by Dr. 
XiaoMing Yang and Dr. Jean-Claude Labbé as described below (page 39-41). 
Worm stocks were grown and maintained on 9 cm NGM agar plates at 16oC as 
described [149]. NGM media was prepared by adding 3 g of NaCl, 2,5 g of 
peptone and 17 g of agar to 975 ml of water, autoclaved, cooled down to 55oC and 
then the following were added in order: 1 ml of cholesterol (5 mg/ml in 100% 
ethanol), 1 ml of 1 M CaCl2, 1 ml of 1 M MgSO4, and 25 ml of 1 M KH2PO4 
adjusted to pH 6.0 by the addition of KOH. 
 The E. coli AP endonuclease deficient strain BW528 (Δ (xth-pnc), 
nfo1::kan) was chosen instead of OP50 to avoid any contamination of the protein 
or the RNA extracts with the bacterial homologue of C. elegans AP endonuclease 
enzymes [177].  
 Bacterial stocks were prepared by growing the BW528 strain overnight 
in 5 ml of liquid Luria Broth (LB) media at 37oC (LB: 16 g tryptone, 10 g yeast 
extract, 5 g NaCl per litre of water). This was followed by sub-culturing the cells 
for an additional 8 hours at 37oC in 50 ml of LB. The bacteria were then harvested 
by centrifugation, re-suspended in an isotonic solution (M9 buffer) and glycerol 
(ratio 1:1) and stored at –80oC. The M9 buffer was prepared by dissolving 6 g of 
Na2HPO4, 3 g of KH2PO4, 5 g of NaCl and 0,25 g of MgSO4·7H2O in 1 L of H2O). 
Prior to plating, the bacterial stock was diluted in M9: glycerol to an O.D. of 0,1. 
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The absorption was measured using a spectrophotometer. BW528 strain was 
spread onto the NGM plates to provide a nutrient source for the worms. 
 A total of 20 nematodes were then transferred to each plate previously 
spread with the E. coli BW528 strain and incubated at 16 oC. In order to maintain 
these cultures at 16 oC, a transfer to freshly prepared and seeded plates must occur 
once every 4-5 days. 
 
2. RNAi knockdown feeding system 
 
 Delivery of the double stranded RNA (dsRNA) that is responsible for the 
knockdown was performed through a feeding system where bacteria expressing 
the dsRNA were used as a food source for the worms [180]. In fact, dsRNA has 
the ability to cross cell membranes and propagate throughout the whole body of 
the worm, causing a systemic knockdown of the target gene simply through 
feeding. 
For this purpose, bacterial strain HT115 (F-, mcrA, mcrB, IN(rrnD-
rrnE)1,rnc14::Tn10(DE3 lysogen: lavUV5 promoter -T7 polymerase IPTG-
inducible, RNAse III minus) lacking the dsRNA-specific RNase, was transformed 
with L4440 vector to stably produce dsRNA of the apn-1 gene. L4440 vector has a 
multiple cloning site (MCS) flanked by two T7 promoters [180]. Since these 
promoters present opposite orientations, transcription in both directions of the 
insert through the T7 promoters leads to the formation of a dsRNA that has an 
identical sequence to the DNA fragment inserted in the MCS [180]. Moreover, the 
HT115 strain has a T7 RNA polymerase gene that is inducible by Isopropyl β-D-1-
thiogalactopyranoside (IPTG) allowing indirect induction of dsRNA production 
[180]. These characteristics of HT115 strain and the L4440 vector provide a great 
system to reach our goal. The bacterial strain and the L4440 vector were obtained 
from Dr. Simon Bulton.  
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2.1. L4440-apn-1 Plasmid preparation (prepared by Dr. 
Andrea Shatilla) 
 
 The preparation of the L4440-apn-1 plasmid started with the amplification 
of a ~900bp piece of the apn-1 gene (nucleotides 46-949) through a PCR reaction. 
The 5’-end of these primers were designed to be cut with the same restriction 
enzymes as those used to linearize the L4440 vector, Kpn I and BamH I. The 
amplification products as well as the L4440 vehicle were treated with the above 
mentioned restriction enzymes for two hours at 37oC to create compatible ends for 
ligation. Prior to ligation, the vector was treated with 0.5 µl of calf intestinal 
phosphatases (CIP) for 30 min at 37oC to remove 5’-phosphate and therefore 
prevent the vector from re-circularizing. Heat inactivation of CIP was performed 
by incubating the sample at 65oC for 15 min. The ligation reaction was incubated 
overnight at 16oC, transformed into competent DH5α, plated on LB agar petri 
dishes and grown overnight at 37 oC.  Single colonies were picked up and plasmid 
DNA was prepared from each colony using QIAprep spin Miniprep Kit from 
QIAGEN. Plasmid DNA was digested using Kpn I, BamH I, and the combination 
of Kpn I and BamH I in order to verify correct ligation. Digestion of the correct 
plasmid with either Kpn I or BamH I are supposed to yield a single band with a 
molecular weight higher than the linearized L4440 vector (3.7 kb vs 2.8 kb, 
respectively), used as a control. On the other hand, the double digestion is 
supposed to produce 2 distinct bands: one of 2.8 kb and the other of 0.9 kb, 
corresponding to the separated vector and insert, respectively. The digestion 
product was visualized on a 1% DNA agarose gel stained with Ethidium Bromide 
(EtBr). One of the colonies presenting the above described digestion pattern was 
inoculated into 2 ml of liquid LB supplemented with 100 µg/ml of ampicilin and 
incubated overnight at 37oC. Plasmid DNA was then extracted using QIAprep 
Spin Miniprep kit (Qiagen). Purified plasmid was used to transform competent 
HT115 bacterial cells using standard transformation procedures. Bacterial cultures 
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and stocks were prepared by inoculating a single colony of the transformed 
bacteria into 2 ml of liquid LB supplemented with ampicillin (100 µg⁄ml) and 
incubated overnight at 37oC. This was followed by sub-culturing the cells for an 
additional 8 h in 50 ml of LB with ampicillin after which cells were harvested by 
centrifugation (4000 rpm for 10 min), re-suspended in M9:glycerol (ratio 1:1) 
aliquoted and stored at -80oC. 
The Taq polymerase and the 10x PCR buffer were from Feldan while the CIP, T4 
DNA ligase and the ligase buffer were purchased from New England Bio labs.  
 
2.2. Preparation of knockdown plates 
 
 Knockdown plates were prepared as described previously [180]. The 
NGM plates used for the knockdown of apn-1 had the same composition as 
described previously with the addition of 25 µg⁄ml of ampicillin and IPTG to a 
final concentration of 1 mM. IPTG induces the T7 RNA polymerase in the 
bacterial strain that in turn, binds to the T7 promoter flanking the multiple cloning 
site in the L4440 vector to enhance the dsRNA production. The addition of 
ampicillin helps prevent the bacteria from losing the plasmid.  
 Prior to plating, the HT115 strain containing the empty L4440 vector or 
the plasmid expressing the dsRNA for apn-1 were inoculated into 2 ml of liquid 
LB supplemented with ampicillin to a final concentration of 100 µg⁄ml. The 
cultures were then shaken for 4-5 hours at 37oC to reach log-phase and 15-20µl 
were spread onto each IPTG and ampicillin containing plate and incubated 
overnight at room temperature. After the overnight incubation, a total number of 
20 L4-adult worms were transferred to each plate, which were then incubated at 
16oC for 4-5 days. 
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3. Verification of the knockdown efficiency through RT-
PCR 
 
 RNA interference is known to induce the degradation of the target 
messenger RNA [174]. Thus, a good way to verify the knockdown efficiency in 
the parental strain is to look at the level of the mRNA before and after the 
knockdown. 
 
3.1. RNA extraction 
 
 Worm cultures were prepared as described previously. About 5 plates, 
containing the C. elegans N2 strain of the control RNAi and 5 of the apn-1 RNAi 
were collected and washed 2-3 times with M9 buffer to remove all traces of the 
feeding bacteria. This was done by centrifugation at 1000 rpm for 4-5 min. After 
the last wash, the worms were transferred into 1.5 ml eppendorf tubes, the buffer 
was removed completely and an equal volume of lysis buffer was added. The lysis 
buffer was composed of 50 µl of 10% SDS, 50 µl of β-mercaptoethanol, 10 µl of 1 
M Tris HCl pH 8.0, 25 µl of proteinase K and 20 µl of 0,5 M EDTA PH 7-8 in a 
total volume of 1 ml. 
 The tubes containing the worms and the lysis buffer were then incubated 
at 42ºC for 15-30 min while re-suspending the precipitated worms once every 5 
min. After the incubation, 1 ml of trizol (Invitrogen) was added and mixed with 
the content of the tube. Three to 5 freeze-thaw cycles in liquid nitrogen were 
performed to further release the RNA from the cells, after which 200 µl of 
chloroform was added and mixed by vortexing for 3-5 min. Tubes were allowed to 
sit for 3 min at room temperature then a centrifugation at 12, 000 xg for 15 min 
was performed in an eppendorf micro-centrifuge at 4ºC. After centrifugation the 
top layer was transferred to new 1.5 ml eppendorf tubes and RNA was precipitated 
 38
by addition of an equal volume of isopropanol, mixing and allowing tubes to sit at 
room temperature for 10 min. After centrifuging at 12, 000 xg for 15 min at 4ºC, 
the RNA pellets were washed with 75% ethanol in RNase free water and 
centrifuged at 7500 xg for 5 min. Finally, the pellets were air-dried briefly and re-
suspended in RNase free water. RNase free water was prepared by adding 500 µl 
of Diethyl pyrocarbonate (DEPC) to 500 ml of water. 
The RNA samples were then treated with DNase to avoid the DNA co-
amplification with the target cDNA during the PCR reaction. This was done using 
a Ribo Pure-yeast kit from Ambion. To each RNA sample, 10X DNase 1 buffer 
and 8 units of DNase 1 were added and mixed. The tubes were then incubated at 
37ºC for 30 min after which the enzyme was inactivated by the addition of 
inactivation reagent. The contents of the tube were mixed by vortexing and 
allowed to sit for 5 min at room temperature. A quick centrifugation for 2-3 min at 
13, 000 rpm allows the precipitation of the inactivation reagent. The solution 
containing the RNA was then transferred into a new tube which was frozen at -80 
ºC until needed. 
 
3.2. Genomic DNA extraction 
 
 The genomic DNA was extracted using the Jorgensen lab’s protocol and 
was used as a positive control for the RT-PCR. Four to five plates containing the 
parental N2 strain grown on the E. coli BW528 were washed 2-3 times by 
centrifugation to eliminate all traces of bacteria. After the last centrifugation, the 
worm pellet was re-suspended in TEN solution containing Tris, EDTA and NaCl 
pH 7.5 to a final concentration of 20 mM, 50 mM and 100 mM respectively. The 
worms were then centrifuged at 1000 rpm for 1 min, the supernatant removed and 
the worm pellet was again re-suspended in an additional 500µl of TEN and then 
transferred into a 1.5 ml eppendorf tube. To the content of the tube, 25 µl of 10% 
SDS and 2.5 µl of 20 mg/ml proteinase K were added, mixed well, and incubated 
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at 55 ºC for one hour. Settled worms were re-suspended once every 10 min. After 
the first hour of incubation, an additional 2.5 µl of proteinase K was added and the 
tube was re-incubated for a second hour at 55 ºC. After the second incubation, a 
phenol extraction was performed followed by a phenol/CIA and finally a CIA 
extraction (CIA=24:1 chloroform: isoamyl alcohol). After each extraction, the top 
layer was transferred into a fresh tube that was kept on ice. To precipitate the 
DNA, 45 µl of 3 M sodium acetate (NaOAc) and 0.8 ml of 100% ethanol were 
added and mixed well with the content of the tube. The DNA precipitates almost 
immediately. A short spin (2-5 sec) is long enough to pull down the DNA. At this 
point the ethanol was drained and then the pellet was washed with 70% ice cold 
ethanol. The wash was eliminated and the pellet was allowed to dry completely. 
The dried pellet was re-suspended in 500 µl of TEN. Since this re-suspension 
appears to be difficult, the tubes were kept overnight at 4 ºC. An RNase treatment 
was then performed to purify the DNA preparation. To do this, 2µl of 10 mg/ml 
RNase A was added and the mixture was incubated at 37 ºC for 1 hour. This 
incubation was followed by a phenol, then a phenol/CIA and finally a CIA 
extraction. The DNA was precipitated by the addition of 45 µl of NaOAc and 800 
µl of 100% ethanol. The pellet was washed with 70% ethanol, drained and allowed 
to completely dry. Finally, the dried pellet was re-suspended in 100 µl of TE 
 
3.3. Reverse-transcriptase (RT)-PCR and q-RT-PCR 
reactions 
 
 RT-PCR was conducted according to standard protocols. The reverse 
transcription part of the reaction was performed using either oligo (dT) primers 
(Amersham Pharmacia Biotech) or the reverse transcription kit with random 
primers (Invitrogen). The PCR reaction was performed using standard Taq 
polymerase and 10x PCR buffer that were purchased from Feldan. Twenty cycle 
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PCR reactions were performed and the resulting products were visualized using an 
agarose gel stained with EtBr. 
q-RT-PCR reactions were performed using 7500 Real Time PCR systems from 
Applied Biosystems. Briefly cDNA from the RT step of the reaction was mixed 
with PerfeCTa SYBR green supermix low ROX (2X) from Quanta Biosciences 
and primers to a final concentration of 5 μM. The obtained results were assessed 
using Microsoft excel software. 
The PCR primers for the apn-1 gene are:  
RRT apn-1 F:   5’-TAGTTCTCGAGACAATGGCTGG-3’  
RRT apn-1 R:             5’-CCAGCAAAAATGTGACACGTG-3’  
 
The PCR primers for the loading control rpb-12 (RNA polymerase II (B) subunit – 
Sequence name: F23B2.13 
 
RRT F23B2.13 F:   5’-CAGGTCAAGCTCATCTCAAGTCA-3’ 
RRT F23B2.13 R:  5’-GCGTCGTACACCATCAACTTTC-3’ 
 
The PCR primers for the unc-22 gene:  
 
RRT unc-22 F:            5’-GATCAAAAGATCAGGATTGAAAGC-3’ 
RRTunc-22 R:             5’-GAATGTTTGTCGCTTCCAGAAG-3’ 
 
 
4. Construction of the APN-1-GFP expressing plasmid, 
microinjection and generation of transgenic worms  
 
 Given that all the experiments performed in this study were based on the 
knockdown of the C. elegans apn-1 gene, the verification of the efficiency of the 
knockdown system on the protein levels had to be verified. Taking into 
consideration that the endogenous level of expression of the studied protein is very 
low for any western blot or activity detection, we used the engineered transgenic 
C. elegans line over-expressing a C-terminal GFP-tagged APN-1 protein to assess 
knockdown efficiency. 
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4.1. Preparation of the pPD95.70-APN-1-GFP plasmid 
(Prepared by Dr. Xiaoming Yang) 
 
 The full length apn-1 gene was amplified using cosmid TO50H plasmid 
and a PCR touchdown program with pfu DNA polymerase (Fermentas). The PCR 
fragments obtained this way contained sequences overlapping with sequences in 
the vector pPD95.70 that contains a GFP gene following the apn-1 promoter 
region. The pPD95.70 vector was digested with restriction enzymes SalI and Sac I. 
The full length apn-1 product was co-transformed along with the linearized vector 
into S. cerevisiae YW465. The colonies were selected on –URA plates and the 
positive colonies were confirmed by Western blot analysis and multiple restriction 
digestions for verification.  
The oligos used for the PCR reaction were: 
Ceapn1-UTR2500-F1: 
CACGAAAGAATCGTCGACTCAAGAAGCAACGCTAGCTG  
and oligo Ceapn1-GFP-R1 
AAACAAGAAGAGCTCTTTCTTTTATCCATATTGT 
 
4.2. Generation of transgenic nematodes (prepared by Dr. 
Jean-claude Labbe) 
 
 Worms were transformed by microinjection as described 
previously [181].Plasmid pPD95.70, containing the wild-type apn-1 gene fused to 
GFP under the control of the apn-1 promoter, was coinjected into the cytoplasmic 
syncytium of  the gonad in wild-type worms along with the transformation marker 
pRF4 [containing a dominant mutation in the collagen gene, rol-6(su1006)] at 
concentrations of ~1 µg/ml and 50 µg/ml, respectively. pRF4 carries the dominant 
mutation Su1006 in the rol-6 collagen gene, which causes animals to roll and 
 42
move in circles, acting as a  marker for the transformation. The high number of 
copies of the plasmid led to the slight over-expression of APN-1-GFP. 
Microinjection of adult hemaphrodites was performed using a zeiss axiovert 10 
micrsocope. The recovered transgenic worms were called the APN-1-GFP strain 
and were used for the assessment of knockdown efficiency. 
 
5. Visualization of APN-1-GFP levels 
 
 Transgenic worms over-expressing the APN-1 protein fused to GFP at 
the C-terminus were used to assess knockdown efficiency by fluorescent 
microscopy. Briefly, the FL strain was grown for 4 days on NGM media plates 
containing 1 mM IPTG and 25 µg⁄ml ampicilin and seeded with the appropriate E. 
coli strains (control and apn-1 RNAi). To be certain that the chosen worms were 
indeed transgenic and over-expressed the GFP tagged protein, and since we had 
previously observed that up to 40% of the transgenic worms were lost with each 
generation, only those that still display the transformation marker were picked and 
examined under the fluorescence microscope. For this purpose, 1 drop of M9 
buffer was placed on a microscope slide and approximately 10 worms were then 
transferred onto the slide and covered with a cover slip, after which the slide was 
directly examined under a Leica, DMRE, Wetzlar fluorescence microscope 
supplemented with a camera. 
 
6. Assessment of knockdown efficiency: Western blot 
analysis 
 
 An alternative way to assess knockdown efficiency was to prepare crude 
extracts of the worms and perform a western blot analysis using the anti-GFP 
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antibody. While GFP visualization by microscopy is easier and faster, this method 
can provide a more quantitative assessment of the knockdown level. 
 
6.1. Preparation of total protein extract 
 
 After 4 to 5 days of RNAi feeding period, 5 apn-1 RNAi plates and 5 
control plates were flooded with sterile M9 buffer to collect the worms in 50 ml 
falcon tubes. The worms were then washed three times each with 40 ml of sterile 
M9 followed by centrifugation at 1000 rpm for 1 min. After the last wash, the M9 
solution was removed and the pellet was re-suspended in extraction buffer (100 
mM TRIS-HCl pH 6,8, 15 % glycerol, 1 mM PMSF and 1 x inhibitor cocktail). 
Total protein extracts were then prepared from the re-suspended worms through 
sonication using Branson Sonifier 250 set at a duty of 50% and an output of 5. The 
sonication process was performed in 15 cylces of 10 sec on ice. 
 
6.2. Western blot analysis 
 
 Western blot analysis was performed according to standard protocols. 
Total protein concentrations were determined using the Bradford analysis. 
Increasing quantities (10-20-40-80 μg) of the total protein extracts obtained from 
the control and apn-1 RNAi worms were loaded onto a 10% SDS polyacrylamide 
gel, which was run at 100 V. The proteins were then transferred to a nitrocellulose 
membrane at 100 V for 1 hour. The membrane was blocked with 5% of skim milk 
in TBSET (6.05 g Tris-Base, 43.83 g NaCl, 1.85 g of EDTA and 500 μl tween 20 
in 500 ml of distilled water and then probed overnight with a mouse-anti-GFP 
monoclonal antibody (Santa Cruz Biotechnology) at a concentration of 1/2500 in 
5% milk. Three successive washes (10 min each) with TBSET were then 
performed to wash all excess of the anti-GFP antibody from the membrane. After 
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the last wash, the membrane was incubated for 1 hour with the anti-mouse 
polyclonal antibody and was followed by 3 washes of 10 min each with TBSET.  
Finally the membrane was incubated for 1 min in chemiluminescence reagent and 
developed using a FujiFilm Intelligent Dark Box supplemented with a LAS-3000 
camera and the Image Reader LAS-3000 Lite software.   
 
7. Detection of the AP endonuclease activity 
 
The detection of AP endonuclease activity in crude extracts obtained from a yeast 
mutant lacking both AP endonuclease enzymes and transformed with the C. 
elegans apn-1 gene led us to assume that the undetectable AP endonuclease 
activity in crude extract derived from the C. elegans parental N2 strain is due to a 
very low expression level of the protein. Thus we decided to investigate whether 
the transgenic worm, expected to over-express APN-1, would express the protein 
at an enzymatically detectable level.  
 
7.1. Preparation of oligonucleotide substrates 
 
 The double stranded substrate used in the AP endonuclease assay was 
prepared as previously described [177, 178]. Briefly, a synthetic 42 mer 
oligonucleotide with a uracil at position 21 was purchased from GIBCO, BRL or 
BioCorp  
(5’-GCTGCATGCCTGCAGGTCGAUTCTAGAGGATCCCGGGTACCT-3’). 
100 ng of this oligonucleotide was 5’-radiolabelled with 50 µCi of [γ-32P] ATP 
(6000 Ci/mmol ; Amersham) using T4 polynucleotide kinase (Promega) as 
previously described [177]. The ethanol-precipitated and gel-purified labelled 
oligonucleotides were annealed with an equimolar concentration of the 
complementary strand 
 45
(3’-CGACGTACGGACGTCCAGCTGAGATCTCCTAGGGCCCATGGA-5’) to 
create a double stranded 5’-labelled substrate with a uracil at position 21.  
The AP site was then generated through the incubation of 32 ng of the 5’-labelled 
double stranded oligonucleotide with 2 units of E. coli Uracil N-glycosylase Ung 
(New England Biolabs). The buffer used for this reaction (buffer D) contained 30 
mM Hepes–KOH (pH 7.6), 50 mM NaCl and 2 mM EDTA. The reaction mixture 
was incubated at 37˚C for 30 min and the enzyme was then heat inactivated by 
incubating at 65˚C for 10 min [178]. 
 
7.2. Enzyme assays 
 
 The AP endonuclease assay was performed by incubating increasing 
quantities (500 ng-1-10-20 μg) of crude extracts obtained from the FL strain with 
0.8 ng of the previously described AP substrate. The buffer used for this reaction 
contained 100 mM Tris-HCL (pH 7.0) and 5 mM MgCl2 in a total volume of 12.5 
µl. The reaction mixture was incubated at 37ºC for 30min after which it was 
stopped by the addition of 5 µl formamide loading buffer (76% formamide, 0.3% 
bromophenol blue, 0.3% xylene cyanole, 10 mM EDTA). The reaction mixtures 
were then heated for 3-5 min at 65 ◦C in order to dissociate the labeled 
oligonucleotides from the DNA-binding proteins. To visualise the digestion 
product, a 10% poly-acrylamide-7 M urea gel was prepared. After the separation 
of the reaction product, the gel was developed by autoradiography or 
phosphoimager [178]. 
 
8. Assessment of the mutation frequency through the 
detection of β-galactosidase Activity 
 
 Staining was performed by a modification of the protocol used by Fire et 
al [182]. The control RNAi and the apn-1 RNAi-treated plates containing the C. 
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elegans NL3400 strain were washed with sterile M9 buffer to collect the worms. 
The worms were then washed 2-3 times with 40 ml of sterile M9 buffer to 
eliminate the bacteria. These washes were done by centrifugation at 1000 rpm for 
1 min. Following the last wash, the M9 buffer was removed completely. The 
worms were then vacuum-dried for 20 min. It appears to be crucial to use 
completely a dried worm pellet for β-galactosidase activity detection. To make 
holes in the cuticle, 35 μl of ice cold acetone was added to the dry worm pellet and 
allowed to completely air dry on the bench (~45 min). This step was repeated once 
more with another 35 μl of ice cold acetone. To the completely dried worm pellet, 
200 μl of freshly prepared oxidation buffer was added and mixed by pipetting. The 
oxidation buffer consisted of 0,2 M sodium phosphate buffer, pH 7,5, 5 mM 
potassium ferricyanide, 5 mM potassium ferrocyanide, 1 mM MgCl2, 0,004% 
sodium dodecyl sulfate, 7,5 μg/ml kanamycin and 0,04% X-gal.  The worms were 
gently mixed with the oxidation buffer and the tubes were covered with aluminium 
foil and incubated overnight at 37oC. For microscopy, the entire worm mixture 
was mixed by pipetting and one drop was placed on a microscope slide and gently 
sealed with a cover slip. All excess fluid was dried with a paper towel, and the 
microscope slide was directly examined under a microscope (Leica, DMRE, 
Wetzlar, Germany) at 250 magnification using immersion oil (Cargille Lab Inc, 
Cedar Grove, NJ, USA). 
Worms were counted from the microscopy images considering the worms 
displaying high number of blue patches to be mutation carriers (accumulated high 
levels of mutations that brought the LacZ gene back into frame) and those with 
few or no patches to not be carrying significant mutations. 
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9. Egg-hatching assay: Test for sensitivity to DNA 
damaging agents 
 
 In order to verify whether the knockdown of the DNA repair gene apn-1 
had any effect on the embryonic development of the nematode C. elegans, we 
developed a protocol in the lab to directly examine this possibility. This protocol 
can be divided into 3 steps: worm culture synchronization, drug plate preparation, 
and worm transfer and incubation. 
 
9.1. Worm culture synchronization 
 
 An average of 30-40 young adult worms were transferred from the 
control or RNAi treated plates to new 9 cm NGM with IPTG and ampicilin plates 
seeded with either the control or knockdown HT115 strain. These worms were 
allowed to lay eggs for a period of 4-5 hours after which they were removed using 
a heated platinum wire attached to a pasteur pipette. The plates containing the eggs 
were then incubated at 16 oC for 3.5 days, resulting in a population of 
synchronized worms at the L4 stage. 
 
9.2. Drug plate preparation 
 
 The egg hatching assay was always done in quadruplicates for each drug 
tested. The drugs tested in this study were H2O2, t-BH and MMS. Other drugs such 
as 4-NQO were tried and then omitted from this study due to stability issues. 
Cisplatin was also omitted due to an unexplained reactivity of this drug in C. 
elegans. UVC treatment was chosen as an alternative to cisplatin since it does not 
cause any damage that is repaired by apn-1.  
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Small, 3 cm plates, were used in this study instead of the larger 9 cm plates used 
previously. The drug concentrations chosen after standardization were 0.07% for 
MMS, 5 μM for t-BH, 0.001% for H2O2 and 150J/cm2 for UVC. As in the 
preparation of the 9 cm knockdown plates, one drop of the log-phase bacterial 
culture was spread to form one thin line of bacteria on the plate. This facilitated 
the counting of the eggs and progeny that remained strictly on the bacterial line. 
 
9.3. Worm transfer and incubations 
 
 Three L4-adult worms were transferred to each 3 cm plate. The plates 
were then incubated for 12-15 hours at 16 oC. After the first incubation, the adult 
worms were removed from the plates and the eggs were counted. The plates were 
then re-incubated and the progeny scored at two time points, namely 24 and 36 
hours. 
 
10. Longevity assay 
 
Culture synchronization and the drug plate preparation were performed as 
described in the egg hatching assay. For this assay, 12 synchronized L4 worms 
were transferred to each 3 cm drug plate.  Plates were then scored daily for any 
dead worms. A stimulation of the immotile nematodes with a platinum wire 
attached to a pastor pipette provided a proof of death. Those that failed to respond 
to this stimulation were considered dead. Three transfers were performed during 
this 1 month experiment. The first transfer was at t=0, the second was at day 3 and 
the last at day 8. These transfers helped avoid drug degradation, media desiccation 
and culture contamination with the progeny and thus, avoid confusion of the 
studied adult worms with the progeny.  
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11. Cell cycle length assessment 
 
 Cell cycle studies were performed with a modification of the protocol 
used by Labbe, J.C. et al. 2006[183]. Briefly, adult worms from the control and 
apn-1 RNAi plates were transferred to a drop of egg buffer [184] placed on a cover 
slide coated with 1% polylysine. Live embryos were obtained by cutting open the 
transferred adult gravid worms using two 25-gauge needles. The cover slip was 
placed on a microscope slide containing a 3% agarose pad in the middle and the 
edges were sealed by Vaseline to prevent the egg buffer from drying. Using an 
Olympus IX71 microscope with a 60X objective, supplemented with a Retiga 
2000R from Qimaging, time-lapse images were taken with 10 sec intervals. Cell 
cycle length was measured by determining the time of each cytokinesis.  
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Chapter 3 – Results 
 
1. Transgenic APN-1-GFP shows increased levels of AP 
endonuclease activity  
 
 As discussed in the introduction, one of the main advantages that C. 
elegans possesses over yeast and bacteria is its anatomical complexity, providing a 
way to assess if APN-1 presents tissue specific expression, and thus presenting a 
possible explanation for the unsuccessful identification of its homologue in 
humans to date. In order to investigate this, we created a transgenic animal 
expressing a GFP tagged APN-1 to follow the expression pattern of the protein in 
the body of the worms using fluorescence microscopy.  
 Briefly, apn-1 plus 2 kb upstream was amplified from the cosmid TOH50 
and subcloned into the pPD95.70 vector such that APN-1-GFP expression is 
driven by its own promoter. As such, the expression level of the fusion protein can 
be controlled by the amount of the introduced plasmid. Unfortunately, the 
injection of the plasmid at any concentration higher than 1 ng/µl appeared to be 
toxic as no transgenic animals were isolated after multiple attempts. However, a 
successful line was isolated when the plasmid was injected at a concentration 
lower than 1 ng/µl. 
 Unfortunately, direct examination of these transgenic animals under 
fluorescent microscopy revealed no detectable levels of GFP when compared to 
the N2 parent; instead only autofluorescent granules normally present in the gut 
were detected (figure 1 A vs B). This observation indicates that the expression 
level of the fusion protein in the isolated transgenic line is not high enough to be 
detected by fluorescent microscopy and therefore is not adequate to directly study 
the distribution of the protein.   
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Figure 1. The APN-1-GFP transgenic line show no detectable GFP as compared to 
the parental N2 strain. Direct visualization of A) parental N2 Strain and B) APN-1-
GFP transgenic worms under fluorescent microscopy. 
 
 Previous attempts failed to detect any Mg2+-independent AP endonuclease 
activity, characteristic of the Endo IV family members, in crude extracts derived 
from the parental N2 worms suggesting no or a very low expression level of the 
APN-1 enzyme in C. elegans (figure 2 B lanes 8-15). Taking into consideration 
that the amount of the injected plasmid might lead to the overexpression of APN-1 
in the isolated transgenic line, crude extracts from this line were assayed for AP 
endonuclease using the well established and highly sensitive AP endonuclease 
assay. This assay allows the detection of AP endonuclease activity using a 42 mer 
radiolabled oligonucleotide containing a centered AP site [177, 179]. The cleavage 
of the AP site by the action of the AP endonuclease enzymes leads to the 
formation of a 20 mer radiolabled fragment that migrates lower on a 10% 
polyacrylamide/7 M urea gels [179]. The assessment of the AP endonuclease 
activity in crude extracts derived from the transgenic line showed a concentration 
dependent Mg2+-independent AP endonuclease activity (figure 2A, lanes 4-7), 
likely reflecting a moderately elevated expression of APN-1 in the APN-1-GFP 
strain as compared to the parental N2 strain (figure 2 A vs B). The apparent 
normal growth of the transgenic worms suggests that the isolated transgenic line is 
capable of tolerating the slight over-expression of the APN-1-GFP fusion protein. 
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Furthermore, western blot analysis using the anti-GFP anti-body of total extracts 
derived from the transgenic line revealed the presence of a major ~75-kDa 
polypeptide that corresponds to the expected size of the full length APN-1-GFP 
fusion protein (figure 3). GFP fragments were also noticeable, suggesting that the 
GFP tag might not be very stable. 
Figure 2. A) Crude extracts derived from the APN-1-GFP transgenic animals possess 
AP endonuclease activity. 
   B) Crude extracts derived from the parental N2 strain are devoid of AP 
endonuclease activity. 
Crude extracts were prepared from the indicated C. elegans strains and monitored 
for AP endonuclease activity using a [32-P] labeled 42-mer oligonucleotide substrate 
containing a single AP site at position 21. A) lane 1, substrate alone, lanes 2 and 3 
substrate with either purified endo IV or purified GST-APN1(yeast), lanes 4-7, 
extracts from the transgenic APN-1-GFP, B) lanes 8-15, increasing quantities of 
crude extracts derived from N2 strain 
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Figure 3. Western blot analysis showing the expression level of APN-1-GFP in the 
transgenic line fed control and apn-1 RNAi. Harvested worms were washed and total 
protein extracts prepared and analyzed by Western blot probed with anti-GFP 
antibody. A) western blot and B) Coomassie stain to monitor for protein loading 
 
2. Overexpression of the long N-terminal domain of 
APN-1 is toxic 
 
 The original annotation of the C. elegans genome identified APN-1 as an 
278 amino acid protein [176]. Recently, an additional in-frame start codon, 
upstream of the gene that would add additional N-terminal 118 amino acids to the 
protein, was identified. We have demonstrated through RT-PCR that these 118 
amino acids are indeed transcribed but we haven’t attempted to validate if they are 
translated as a part of the full length protein (data not shown). This unusually long 
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N-terminal region is not present in any of the other Endo IV family members from 
other species, except for close relatives to C. elegans such as C. briggsae (figure 
4). 
 In yeast, the C-terminal sequence of Apn1 interacts with Pir1, which 
mediates translocation of Apn1 into the mitochondria [102].  Based on this, and 
since the long N-terminal region of APN-1 is found in other close relatives to C. 
elegans, we wished to test whether the additional sequence of APN1 might serve 
as a localization signal to target the protein to a specific subcellular compartment.  
In order to verify this hypothesis we attempted to construct a C. elegans transgenic 
line, over-expressing the N-terminal 118 amino acids tagged with GFP. We were 
hoping to follow the distribution of the N-terminal region of APN-1 and eventually 
attempt to identify factors that might be interacting with this portion of the protein. 
However, the injection of the plasmid expressing the N-terminal-GFP fusion was 
found to be toxic for the worms, and no transgenic lines were isolated even after 
the injection of very low plasmid concentrations (data not shown)(see discussion). 
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3. Confirmation of knockdown by Q-RT PCR 
 
 The development of reverse genetics techniques presented ways for the 
easy assessment of gene function. In our study, we used RNAi knockdown to 
decrease the expression of the apn-1 gene and study the consequence of this 
decrease on different life aspects of the nematodes. 
 To determine whether our RNAi construct knocked down apn-1 message, 
we used real time and RT PCR to detect changes in mRNA levels in wild type 
animals, as it is thought that gene knockdown with RNAi in C. elegans acts 
through the degradation of the corresponding mRNA. Total RNA was extracted 
from the parental N2 worms obtained from either apn-1 knockdown or the RNAi 
control plates as described previously. The quality of the extracted RNA was 
verified by agarose gel electrophoresis (figure 5). 
 While RT- PCR experiments clearly indicated decreased levels of apn-1 
mRNA as verified by 1.5% agarose gel (data not shown), it failed to give a 
quantitative assessment of the knockdown. For this purpose, q-RT-PCR reactions 
were conducted. The collected data clearly indicates a reduction of 60% of the 
level of the apn-1 message in the knockdown sample as compared to the control 
(figure 6). It is important to note here that the level of apn-1 knockdown was lower 
than the level of the control unc-22, a muscle gene typically used in RNAi 
experiments [185]. 
Figure 5. RNase free agarose gel revealing the quality of the extracted RNA samples. 
RNA extracts treated with DNase, were run on a 1% RNase free agarose gel and 
stained with ethidium bromide.  
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Figure 6. Percentage of the remaining unc-22 and apn-1 message following gene 
specific RNAi. unc-22 and apn-1 genes were knockdown separately through feeding 
(materials and methods). RNA was extracted and qRT-PCR experiments were 
conducted using standard protocols.  
 
4. Confirmation of knockdown by Western Blot 
  
 The very low expression level of the APN1 protein in the parental C. 
elegans N2 strain and the absence of an appropriate anti-APN-1 antibody to detect 
it, led us to exploit the APN-1-GFP line to verify the efficiency of knockdown. For 
this purpose, increasing amounts of crude extracts from the transgenic line derived 
from the control and the apn-1 RNAi plates were run on a 10% SDS-
polyacrylamide gel, transferred into a nitrocellulose membrane and probed with an 
anti-GFP monoclonal antibody.  As shown in figure 6, the APN-1-GFP level 
clearly decreased following the RNAi treatment as compared to the control vector 
(figure 3 lanes 6-10 versus lanes 1-5). 
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5. apn-1 knockdown increases the frequency of 
spontaneous frameshift mutations 
 
 Since AP endonucleases have a direct role in maintaining the stability of 
the genome, we reasoned that knockdown of this gene could result in an increase 
in the mutation frequency. This is normally due to translesion synthesis that 
bypasses DNA lesion, by the possible incorporation of a wrong nucleotide, when 
DNA repair is compromised [45, 48]. To assess this, we used an established and 
sensitive β-galactosidase reporter assay that allows the detection of frameshift 
mutations resulting from small insertions and deletions in somatic cells of C. 
elegans [186].  The β-gal reporter is placed out of frame by a 17 A repeat inserted 
between the ATG and the gfp-LacZ open reading frame, and integrated in the C. 
elegans genome as a multicopy array to create the NL3400 strain [186]. A 
mutation that restores the reading frame of any single copy of the reporter can be 
visualized by β-galactosidase staining as a blue cell or a group of blue cells 
corresponding to a mutated cell that has since divided [186]. This assay has been 
used to identify several genes in C. elegans that affect genetic stability, such as the 
DNA mismatch repair gene msh-6 [187]. 
 Interestingly, increased blue coloring was observed in a population of 
apn-1 knockdown worms as compared to the control RNAi population, indicating 
an increased frequency of mutations (fig. 7). Furthermore, direct comparison of the 
apn-1 knockdown sample and the control sample under optical microscopy 
revealed ~ 5-fold increase in the mutation frequency following apn-1 knockdown. 
At least 85% of the knockdown worms contained mutations as compared to 18% 
in the control (figure 8). In addition, apn-1 knockdown worms often had multiple 
blue patches, indicating that multiple mutation events occurred in a single worm 
(figure 9 panel B).   
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Figure 7. apn-1-RNAi worms exhibit 
elevated mutations as assessed by the β-galactosidase reporter gene. Control and 
apn-1 RNAi worms (4 days) were harvested and processed for β-activity (see 
materials and methods) and total worm populations were photographed by a digital 
camera. 
Figure 8. Percentage of worms with mutations in the 17A inserted adjacent to the 
ATG of the β-galactosidase gene. Control and apn-1 RNAi worms (4 days) were 
harvested and processed for β-gal activity before being visualized and counted under 
standard light microscopy. 
 
Since aged worms were stained in both populations, the above results 
represent the staining of the young L1 and L2 worms (figure 9). Moreover, what 
was remarkably different between the two samples was the fact that eggs were 
almost exclusively stained when apn-1 gene was knockdown (figure 10 B marked 
by arrows). This data suggest that APN-1 is implicated in maintaining genomic 
integrity and might be particularly needed during early development.  
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Figure 9. apn-1 RNAi worms exhibit elevated mutations as assessed by the β-gal 
reporter. Control and apn-1 RNAi worms (4days) were harvested and processed for 
β-gal activity (materials and methods). A) control RNAi and B) apn-1 RNAi worms 
photographed under a light microscope. The eggs are marked with black arrows. 
 
 Surprisingly the β-gal staining was mainly located in the gut and the 
central nervous system of the worm (fig. 10) suggesting that the cells of these 
tissues are more susceptible to mutations then other tissues when the DNA repair 
gene apn-1 is knocked down. This observation suggests a possible tissue specific 
distribution of the APN-1 protein in the worm or that APN-1 is more needed to 
preserve the DNA integrity specifically in these tissues.  
 
 
 
Figure 10. The X-Gal staining is mainly 
localized to the gut and central nervous 
system of the worms. 
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6. Knockdown of apn-1 causes the accumulation of 
unhatched eggs 
 
 The results obtained from the mutation frequency assay pointed towards 
loss of genomic stability due to the decreased expression of an important DNA 
repair gene. We therefore anticipate that the elevated mutation frequency would 
present some consequences on the living organism.  We observed unhatched eggs 
accumulating in the plates with the knockdown as compared to the control animals 
(fig. 11 A vs B). This observation coincides with exclusive β-galactosidase 
staining of eggs in knockdown plates as compared to the control. 
 
Figure 11. The knockdown of the apn-1 gene causes the accumulation of unhatched 
eggs. Control and apn-1 RNAi N2 worms were photographed (4-5 days after 
incubation at 16ºC) using a digital camera fixed on the binocular lens (microscope 
type). Unhatched eggs are marked with an arrow. 
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7. RNAi-apn-1 knockdown delays the development of 
the parent N2 strain and sensitizes worms to different 
DNA damaging agents 
 
 In order to further analyze the effect of the apn-1 knockdown on egg 
viability, a protocol was developed in our laboratory to measure the percentage of 
hatched eggs in the presence or absence of DNA damaging agents. Briefly, apn-1 
knockdown and control worms were synchronized and three L4-adult worms were 
transferred to plates containing DNA damaging agents. After 12-15 hours, the 
adults were removed and the eggs were counted. The plates were then re-incubated 
before being scored at two different time points, namely 24 and 36 h. For UVC 
treatment, the L4 worms were irradiated directly on the plates followed by the 
same steps as above. 
 When no DNA damaging agents are used, apn-1 knockdown animals 
showed 30 + 8% reduction of the population at 24 hours when compared to the 
control animals fed either the empty L4440 vector (Figure 12 panel A) or 
expressing a negative control RNAi that is RNAi-6G5 (data not shown). 
Interestingly, at 36 hours, the observed difference in the progeny size between the 
apn-1 knockdown and the control decreased from 30 to 10 + 3% (figure 12 panel 
B). Further, incubation did not improve the progeny size, suggesting that RNAi-
apn-1 knockdown diminishes the survival of a fraction of the progeny (data not 
shown). 
  When treating with DNA damaging agents, apn-1 knockdown 
animals were found to be sensitive to hydrogen peroxide (H2O2), tert-
butylhydroperoxide (t-BH) and methyl methane sufonate (MMS), showing 75 + 
11, 46 + 6 and 33 + 12% decrease in the progeny size at 24 h, respectively, 
normalized to the control RNAi for each DNA damaging agent tested (figure 12 
panel A). On the other hand, at 24h, the UVC treatment did not show any decrease 
in the progeny size between the control and the apn-1 animals (figure 12 panel A). 
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Similarly to what was observed in the absence of genotoxic stress, the observed 
gap in the progeny size between the control and the apn-1 knockdown was 
partially recovered after an additional 12 hours incubation of the plates when 
treated with H2O2 and t-BH. At 36 h, the observed gap in progeny size between 
control and apn-1 RNAi animals, following H2O2 and t-BH treatment reached 30 + 
8 and 25 + 7 respectively (figure 12 panel B). Further incubations did not improve 
the progeny size (data not shown). Interestingly, the MMS-treated RNAi-apn-1 
knockdown did not show any recovery showing 31 + 11 % decreased in the 
progeny size (figure 12 panel B). 
  We interpret these data to indicate that RNAi-apn-1 knockdown is 
causing (i) a delay in the progeny size, which is substantially elevated by H2O2 
treatment and to a lesser extent by tert-BH, but not by MMS, and (ii) death in a 
fraction of the population which is enhanced by H2O2, T-BH and MMS treatment, 
but not by UVC (see discussion).  Thus, it would appear that APN-1 plays a more 
prominent role in protecting the animals from the genotoxic effects of certain types 
of oxidized DNA lesions, as opposed to alkylation DNA damage and pyrimidine 
dimers. In fact, it is somewhat surprising that the RNAi-apn-1 knockdown animals 
were no more sensitive to MMS than the untreated control during the first 24 h of 
exposure.   
 64
Figure 12. Spontaneous and drug-induced levels of mutations affect progeny 
size in apn-1 RNAi animals. Briefly, control and apn-1 RNAi treated adult 
worms (2-3) were transferred in quadruplicates onto plates without and with 
the indicated damaging agents. 12 to 15 hours after incubation, the adults 
were removed and the embryos were counted. The plates were reincubated 
before being scored at 2 time points: 24 and 36 hours. A) percentage of 
hatched eggs at 24 hours, B) percentage of hatched eggs at 36 hours. 
Percentage of hatching of the apn-1 RNAi in A) and B) were normalized 
against control RNAi. 
 
8. RNAi-apn-1 knockdown delays cell cycle progression 
 
 We next examined the cell cycle progression of individual single cell 
embryos derived from the control and apn-1 knockdown animals using time-lapse 
microscopy.  For this experiment, and for each treatment, we checked a total of 8 
single cell embryos for the length of time for cell division from 2 to 4 cells to 
occur.  The wild type single cell embryo, termed P0, divides asymmetrically into a 
larger anterior AB cell and a smaller posterior P1 cell. The AB cell then divides 
into an the anterior daughter ABa cell and the posterior daughter cell Abp, while ~ 
2 min later, the P1 cell divides into P2 and EMS cells. The observed gap between 
the P1 and the AB divisions is partially due to the presence of checkpoint signaling 
in the P1 cell while it is believed to be silenced in the AB cell.  Following apn-1 
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knockdown, we observed that the posterior P1 cell delayed by 38.8 + 0.6 sec when 
compared to the control RNAi, whereas the anterior AB cell did not show any 
significant delay (figure 13 and data not shown).  One possible explanation for the 
P1 delay could be the results of the accumulation of unrepaired spontaneous 
lesions in the apn-1 knockdown.  Even though preliminary, treatment with t-BH 
led to an increased delay in P1 division. This delay reached 105 + 48.3 sec 
between the control and the knockdown embryos, while once again no significant 
delay was detected in the AB cell division (figure 13 and data not shown).  The 
dose of UVC used led to a delay in the cell cycle progression in the control as well 
as the apn-1 RNAi samples. However there was no apparent delay in either P1 or 
AB cell division between the control to apn-1 knockdown, indicating that the 
observed delay is only due to damages that are repaired by apn-1 (figure 13). 
 The collection of data suggests that the mutations observed as a result of 
apn-1 knockdown and the hatching delay caused upon exposure to the DNA 
damaging agents might be due to an arrest in cell cycle progression. We predict 
that apn-1 knockdown would promote the action of alternative mechanisms such 
as error prone translesion pathway to bypass the damage before allowing 
completion of the cell division. 
Figure 13. Cell cycle delay of embryonic P1 cell following apn-1 knockdown. Worms 
were dissected to extract the embryos which were monitored throughout the first 3 
cell divisions using time-laps microscopy. The time interval between the 2 and 4 cell 
embryo was recorded.  
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9. Knockdown of apn-1 decreases lifespan in the 
presence of agents that cause AP sites 
 
 The fact that the knockdown of apn-1 decreased the percentage of 
hatched eggs raised the question of whether it could have an effect on life span of 
the worm. To answer this question, a longevity assay was conducted on worm 
cultures in the presence and absence of multiple DNA damaging agents as 
described in the materials and methods. The agents chosen for this study were t-
BH (final concentration 20 μM), MMS (final concentration 0.07%), 4NQO (final 
concentration 1 μg/ml) and UVC (final dose 150J/m2). 
 Interestingly, the knockdown of the DNA repair gene apn-1 alone was 
not found to have any effect on the overall longevity of the worms as 50% of the 
population died off in ~ 16 days in both control and apn-1 RNAi populations (fig 
14 A). However, the addition of DNA damaging agents that are known to create 
AP sites, such as t-BH and MMS were found to slightly decrease the overall 
longevity of the apn-1 knockdown worms, with 50% of the population dying in 11 
and 14 days respectively, while the vector control fed animals showed a 50% 
decrease in the population within 16 and 17 days respectively (figure 14 panels B 
and C). By contrast, the longevity of the worms was not found to be altered by the 
knockdown of apn-1, when the worms were challenged with agents that do not 
create DNA damages that are repaired by the AP endonuclease enzymes, such as 
4-NQO and UVC, with 50% of the population dying at 15 and 11 days 
respectively Figure 14 D and E). These results further confirmed the importance of 
APN-1 in counteracting the deleterious effect of DNA damages and pointed once 
again to its primary importance during early embryogenesis as no decrease in 
longevity was observed upon apn-1 knockdown alone. 
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Figure 14. apn-1 RNAi worms display shorten life-span when exposed to t-BH 
and MMS, and not to 4-NQO or UVC. Briefly, control and apn-1 RNAi (12 
worms each) were transferred in quadruplicates onto plates without and with 
the indicated DNA damaging agents (t-BH, MMS, and 4-NQO) and 
containing a line of the respective feeding bacteria. For UVC, worms were 
irradiated on the feeding plate with a single dose. Worms were transferred 
onto fresh drug plates on day 3 and day 7. The data is representative of three 
independent analyses. 
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Chapter 4 – Discussion 
 
 To date, the first and only multicellular organism where members of the 
two AP endonuclease families, Endo IV and Exo III, were identified is C. elegans. 
Despite the high structural homology that APN-1 and EXO-3 present when 
compared to their E. coli and S. cerevisiae homologues, all previous studies 
aiming at elucidating their role, were done in the context of ectopic expression in 
yeast, and not in C. elegans itself.   
 In the present study, we have investigated the in vivo function of one of 
these 2 genes, i.e. apn-1, using gene specific RNAi as a tool and the natural host as 
the biological model.  Here, we report strong evidence implicating APN-1 in the 
repair of DNA damage in vivo as it was found essential in preserving the genomic 
integrity of C. elegans. This is supported by the observations that knockdown of 
apn-1 expression (i) substantially elevated the level of spontaneous mutations as 
determined by using a well-defined GFP::lacZ reporter [186], and (ii) caused 
sensitivity to a subset of genotoxic agents that are known to produce DNA lesions 
that require processing by AP endonucleases and 3’-diesterases [41]. This is 
entirely consistent with our previous study showing that expression of APN-1 in 
yeast produced a protein with both AP endonuclease and 3’-diesterase activities 
[178]. While we showed by quantitative PCR that apn-1 RNAi decreased the gene 
expression, and expected a corresponding decrease in APN-1 enzymatic activities, 
these activities were difficult to detect in total extracts derived from parental C. 
elegans.  In fact, the AP endonuclease activity of APN-1 can only be detected if 
instead the total extract was derived from transgenic animals carrying additional 
copies of the apn-1 gene, suggesting that the APN-1 protein is weakly expressed, 
but likely bears high specificity towards DNA lesions.  
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1. Genome-wide screen for the identification of genes 
involved in the maintenance of DNA integrity failed to 
identify apn-1 
 
 Although we were able to clearly show increased mutagenesis in C. 
elegans following apn-1 knockdown, a previous genome wide screen for genes 
implicated in protecting the C. elegans genome against mutations, failed to 
identify apn-1 as an important contributor to genomic stability, with both studies 
using β-galactosidase assay to assess mutation frequency [187]. Thus, it seems that 
for an unknown reason, some genes have eluded the screen and were not picked 
up. One possibility that could explain the absence of apn-1 in the screen is the 
difference in the feeding conditions that were used in the two cases with the 
knockdown in our study performed at 16ºC and the genome-wide screen at 20ºC 
[187]. This might have led to an ineffective knockdown of apn-1 in the genome 
wide screen, as it has been previously reported that the knockdown effectiveness 
of a limited number of genes is somehow affected by temperature, whereas the 
knockdown of the rest of the genome is not [180]. Accordingly, the consequence 
of temperature on the effectiveness of apn-1 knockdown needs to be addressed in 
future experiments. Another possibility that could explain the obtained 
contradicting results is the protocol used for the β-galactosidase assay. Taking into 
consideration that the out of frame β-galactosidase genes are under the control of 
the heat chock hsp16 promoter in the NL3400 strain, we heat shocked culture 
plates for 2 hours at 33 ºC  prior to collecting the worms in order to increase the 
expression of the β-galactosidase genes that were placed back into frame due to 
mutations. This induction step, however, was not done in the genome-wide screen, 
thus, suggesting that apn-1 might be a false negative in the latter study [187]. 
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2.  APN-1 function seems essential for C. elegans 
embryogenesis 
 
 In our study, we have showed that knockdown of apn-1 alone does not 
decrease the longevity of the studied nematodes, whereas it was found to decrease 
the viability of the embryos as shown in the egg hatching assay suggesting that  
APN-1 function is more required during the embryonic development of the 
nematode than it is during later developmental stages of the worm. In fact, it was 
shown in a previous study, using microarray technology, that apn-1 expression is 
highly enriched in C. elegans germline, suggesting a basic role of APN-1 during 
meiosis [188]. Taking into consideration that a high proportion of the genes that 
are enriched in the germline present an important role during embryogenesis [189], 
we propose that apn-1 is most probably important for the proper progression of 
embryonic development. This might suggest a similar enrichment in the 
expression level of apn-1 during embryogenesis as compared to later stages of the 
nematode’s development. If this is the case, one would expect high levels of 
mutations in the embryos and young juvenile as compared to more aged worms, 
which is the case as shown in the β-galactosidase assay. Furthermore, it would be 
logical to assume that APN-1 is more needed during the embryonic development 
of the worm as it constitutes the phase with the most cellular divisions. 
 The relatively low numbers of blue stained young adult when compared 
to embryos and juveniles might be due to a lethality caused by the accumulated 
mutations from early embryogenesis till adulthood. Moreover, those that show 
normal survival and growth, might be either refractive for knockdown for a reason 
that is not very well understood, or did not accumulated enough mutations that 
lead to cell death. In either way, this data strongly suggest a more prominent role 
for APN-1 during the early development of C. elegans, and thus could suggest a 
similar expression of the APN-1 homologue in humans if ever one do exist.  
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3. Possible redundancy between APN-1 and EXO-3 
 
 Although we were able to identify some phenotypes associated with the 
elevated mutation frequency resulting from apn-1 knockdown, the level of the 
observed sensitivity was rather slim, suggesting that the spontaneous or drug 
induced damages were still repaired by some mean. 
 On one hand, we have revealed by qRT-PCR that the knockdown of apn-
1 through feeding, while using the optimal conditions as described previously 
[180], resulted in a decrease in the apn-1 message by 60%. Considering that a 
corresponding decrease in the APN-1 level occurs following the knockdown, a 
40% residual activity will still be present in the cells, and might account for the 
partial repair of the inflicted DNA damage, resulting in a weak phenotype, 
similarly to what was previously reported with yeast [101].  
 On the other hand, the presence of a redundant protein that can substitute 
for the absence of APN-1 could also explain the observed weak phenotype. 
Indeed, similarly to E. coli and S. cerevisiae, the C. elegans genome was found to 
contain a second AP endonuclease, EXO-3, homologue of E. coli exonuclease III. 
In fact, it has been well documented previously that, although the families have 
certain substrate preference, they can complement the absence of one another 
[178]. This was exemplified by the fact that yeast apn1Δ cells are not very 
sensitive to AP site-creating DNA damaging agents unless apn2 is also deleted 
[70]. Furthermore, multiple studies have revealed the predominance of one family 
over the other depending on the studied model system [41]. Whereas exonuclease 
III constitutes the major AP endonuclease enzyme in E. coli, the Endo IV family 
member Apn1 was found to be major AP endonuclease in S. cerevisiae [41]. Thus, 
C. elegans EXO-3 likely provides a second mechanism for repairing AP sites.  
 The inability of EXO-3 to fully complement the absence of APN-1 can 
be mainly explained as a difference in the substrate recognition specificity 
between the two enzymes rather than being related to the predominance of APN-1 
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over EXO-3. This is supported by the identification of EXO-3 as an important 
enzyme for the maintenance of genomic stability in the genome wide screen 
described earlier [187]. Furthermore, nothing is known so far regarding the 
contribution of each of the two families of AP endonuclease enzymes in C. 
elegans.  
 
4. APN-1 is essential for the repair of H2O2 induced 
damage  
 
 In E. coli or yeast, the deficiency of endo IV or Apn1, respectively, 
showed no striking sensitivity to the chemical oxidant H2O2 [104].  Interestingly, 
in C. elegans the knockdown of apn-1 caused significant sensitivity to this agent.  
We reasoned that since C. elegans lacks the DNA glycosylase OGG1 that excises, 
for example, the H2O2-induced oxidized base damage 8-oxo-7,8-dihydro-2'-
deoxyguanosine (8-oxo-dGuo), then removal of such lesion could depend upon the 
nucleotide incision repair activity of APN-1 (Yang et al., in preparation), and/or 
the 3’ to 5’-exonuclease activity of APN-1 might be required to prevent the 
misincorporation of 8-oxo-dGuo from the oxidized dNTP pool into the DNA as we 
have previously shown for yeast Apn1 [98].  In addition, C. elegans genome also 
lacks another key enzyme Tpp1/PNKP of the BER pathway, which in yeast (Tpp1) 
or human (PNKP) functions to remove 3’-phosphate left at DNA single strand 
breaks following exposure to H2O2 [190]. Thus, removal of H2O2-induced 3’-
phosphate would rely on the 3’-diesterase activity of APN-1.  
 
5. Overexpression of apn-1 is toxic 
 
 To study the localization of APN-1 in the worm, we attempted to 
construct a transgenic C. elegans line that overexpresses APN-1-GFP fusion 
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protein. This is usually done through the injection of a plasmid expressing the 
fusion protein along with another expressing a mutated rol-6 gene that is used as a 
transformation maker. Since the used plasmids possess similar DNA backbones, 
they will create extrachromosomal arrays after injection through homologous 
recombination [191]. The isolated transformed lines showing the transformation 
maker will almost always contain the co-injected sequence in the formed array 
[149]. These arrays will express the two proteins at a level that is dependent on the 
concentration at which the plasmids were initially injected [149]. The transmission 
of the array from parent to progeny indicates successful line formation. In most 
cases the plasmid expressing the desired protein is injected at a concentration of 
100 ng/µl whereas the transformation marker is injected at a concentration of 50 
ng/µl [149]. Surprisingly, injection of the APN-1-GFP plasmid at any 
concentration higher than 1 ng/µl failed to produce stable lines. This observation 
might be due to the fact that Apn1 overexpression is either toxic to the worm or 
interferes with the array formation after injection.  
 In the first case, the massive conversion of primary damages, such as AP 
sites, that are highly mutagenic, but not very lethal, into a more toxic and/or 
mutagenic DNA repair intermediate, such as single strand breaks, might be at the 
origin of the observed toxicity. Similar switch to more toxic intermediates have 
also been previously reported in yeast where deletion of mag1 rescued the MMS 
sensitivity of an apn1 apn2 null strain by preventing 3-Methyladenine conversion 
to AP sites [192]. Furthermore, C. elegans APN-1 was found to take part in the 
NIR pathway (manuscript in preparation), thus allowing the direct conversion of 
oxidized bases into the highly toxic single strand break that will block DNA 
replication and may lead to apoptosis. 
 In the second case, the 3’Æ5’ exonuclease activity of APN-1 might be 
removing the 3’-overhangs necessary for the invasion phase of homologous 
recombination, thus preventing the array formation. This is true only if APN-1-
GFP plasmid start being expressed right after the injection. 
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Interestingly, the APN-1-GFP overexpression line that we were able to isolate 
after the injection of the APN-1-GFP plasmid at a concentration of 1ng/µl, showed 
a high incidence of males and a short life span. A high incidence of males may 
indicate genomic instability, as it normally results from meiotic non-disjunction of 
the sexual X chromosomes. When this occurs the resulting gamete that is void of 
the X chromosome gives rise to a male after fecundation. Thus, the high incidence 
of male observed might be explained by the fact that the high concentration of the 
APN-1 protein is creating many DNA lesions, leading to chromosomal fusion, re-
arrangement as well as segregation defects, fusing in some cases the X 
chromosomes and leading to the production of males. If that is the case, the 
increased DNA lesions might also explain the sickness and the short life span 
observed in this line. 
 The surprising observation that overexpression of the N-terminal 118 
amino-acids of APN-1 in C. elegans is toxic suggests that the toxicity observed 
when the plasmid expressing the full length APN-1-GFP fusion protein was 
injected at relatively high concentrations might also be due to the N-terminal 
portion and not the actual nuclease activity of the protein. Since this N-terminal 
part of the protein might be involved in the localization of the protein, its 
overexpression might lead to its accumulation in massive quantities in the nucleus 
and/or mitochondria, thus blocking the normal functioning of these two cellular 
compartments and leading to lethality. On the other hand, the over-expressed N-
terminal portion of the protein might be causing a dominant negative effect by 
blocking, for example, the appropriate binding of the endogenous protein to the 
damage site on the DNA. 
 To try and solve this dilemma, we are presently preparing a transgenic 
line over-expressing the APN-1-GFP protein lacking the N-terminal sequence. The 
successful isolation of a transgenic line using high concentration of injected 
plasmid might confirm that the previously observed toxicity is due to the N-
terminal sequence. However, the simple isolation of a transgenic line will not 
necessarily mean that the N-terminal portion is the only toxic part. In fact, another 
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possibility suggests that if the N-terminal region is a localization signal, then the 
protein might accumulate in the cytoplasm instead of being in the nucleus and/or 
mitochondria to cause the toxicity. Thus, additional experiments including 
immunostaining and GFP visualization will be needed to verify that the active part 
of the protein is still accessing the DNA. 
 
6. The C. elegans RNAi hypersensitive rrf-3 strain behave 
similarly to the parental N2 strain 
 
 It has been previously shown that gene knockdown through RNAi is not 
effective for the genes expressed in the central nervous system [193]. As discussed 
earlier, we have found that the APN-1 protein is mainly localized in the gut of the 
worm. However, we have also noticed that the protein might be expressed in the 
central nervous system where it is refractory for knockdown through RNAi. For 
this purpose, we have assayed the C. elegans RNAi hypersensitive rrf-3 strain for 
sensitivity to multiple DNA damaging agents mainly through the egg hatching 
assay in the hope of conforming or rejecting the previously established 
observation. The main advantage of this strain is that it provides an effective 
knockdown in the central nervous system resulting in an increased sensitivity to 
certain DNA damaging agents if the APN-1 is also expressed in this tissue [193]. 
Surprisingly, the results obtained with the rrf-3 strain were closely comparable to 
those obtained with the parent N2 strain suggesting that the APN-1 protein is most 
probably not or weakly expressed in the central nervous system. Moreover, the 
observed difference between the N2 and the rrf-3 strains is due to a probable more 
effective knockdown when using the hypersensitive strain. However, the discussed 
results are rather preliminary and thus require further investigation to be 
confirmed. 
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7. Future plans 
 
 Despite the successful establishment of a biological role for APN-1 throughout 
the course of this study, more detailed aspects of the involvement of this enzyme in DNA 
repair still needs to be investigated. 
 
7.1. Mutational spectrum resulting from apn-1 
knockdown 
 
 The results obtained in the beta-galactosidase assay clearly indicated an 
increase in the mutation frequency but failed to provide an insight on the 
mutational spectrum that is occurring in the cells as a result of the apn-1 
knockdown. In fact, the C. elegans NL3400 strain highly expresses an out of frame 
beta-galactosidase gene that can be put back into frame through unrepaired 
damages to produce a functional protein. The only mutations that allow this 
transition are frame shifts that occur through base addition or deletion. Base 
substitution on the other hand does not change the coding frame and thus cannot 
attribute to the observed increase in the mutation frequency.  
 To better understand the types of mutations that are normally prevented 
by the action of the apn-1 gene in vivo, it would be essential to get a better 
understanding of the mutation spectrum that is occurring in the genome. For this 
purpose we have chosen a well described C. elegans strain, the SP457 that possess 
an unc-93 (e1500) III mutation [187, 194]. Worms possessing an e1500 mutation 
show an abnormal muscle structure/function rendering the worms almost 
paralyzed and partially egg laying defective [194]. In fact it has been shown that 
the product of the e1500 allele is toxic and that this toxicity is abolished following 
mutations that generates null unc-93 gene [194]. Thus, any unrepaired mutation 
occurring in the unc-93 gene has the potential to allow the reversion of the SP457 
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worms to the wild type phenotype [187]. Revertants will then be selected and 
grown. The DNA will then be extracted from the population of revertants and the 
unc-93 gene will be sequenced to reveal the type of occurred mutations. 
 
7.2. Study of the contribution of the two families of AP 
endonuclease/3’-diesterase in C. elegans 
 
 One of the missing chapters of the presented work is the detailed 
contribution of each of the two AP endonuclease enzymes present in the 
nematode. To investigate this, we are planning to knockdown exo-3 and perform a 
similar set of experiments as with apn-1 knockdown to investigate the implication 
of the EXO-3 enzyme in the BER pathway and in repairing specific types of 
lesions caused by specific DNA damaging agents. We expect to get a similar if not 
a higher sensitivity when exo-3 is knockdown as compared to apn-1, thus 
explaining the resistance observed in the present study. However, we also 
anticipate finding a certain preference of each of the two enzymes to repair 
specific types of lesions, such as seen when these enzymes were used in cross-
species complementation assays [178]. 
 To further understand the contribution of each of the two enzymes to 
DNA repair, we are planning to perform a double knockdown of both apn-1 and 
exo-3 genes and then study the resulting effect on the animals. This double 
knockdown is expected to produce a much higher sensitivity if not lethality if the 
knockdown is very effective, as the worms will be left with little defense against 
DNA damage. 
 An alternative and better way to achieve this goal is by creating knockout 
animals for each of the two genes. This will prevent complicated interpretation of 
possibly weak phenotypes that are due to the residual activity that is left following 
the knockdown. Then the knockout worms will be knocked down for the second 
enzymes and a similar set of experiments will be conducted to study the resulting 
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phenotype. However, it might be relatively expensive and hard to obtain 
knockouts for these genes as the knockout might be lethal, or the resulting animals 
might be extremely sick.  
 
7.3. In depth Cell cycle arrest studies following apn-1 
knockdown 
 
 The cell cycle progression delay that we observed in the P1 cell 
following apn-1 knockdown was significant and explained the observed delay in 
the egg hatching experiments. However, the exact mechanisms behind this delay 
are still unclear. Previous studies pointed out that replication stress leads to a delay 
in the S phase of the first cell cycles of a C. elegans embryo [195]. This delay was 
found to depend on the DNA replication checkpoint genes, notably atl-1 and chk-
1, encoding the homologues of mammalian ATR and Chk1 kinases, respectively 
[195].   
 In order to further confirm our data, we propose to perform double 
knockdown experiments in which we decrease the expression of both apn-1 and 
one of the two checkpoint proteins. This will allow us to investigate whether the 
observed delay is indeed caused by checkpoint arrest triggered by the inflicted 
DNA damage that is increased due to apn-1 absence.  
 
8. Conclusion 
 
 Members of the endo IV family, including C. elegans APN-1, possess 
multiple DNA repair activities that encompass AP endonuclease, 3’-diesterase, 
nucleotide incision and 3’ to 5’-exonuclease allowing this class of enzymes to act 
on various DNA lesions [72].  As such, it seems logical that C. elegans has 
evolved to retain this versatile enzyme, particularly since it lacks a full 
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complement of the BER enzymes, as we noticed while searching the database 
(e.g., OGG1 and Tpp1/PNKP), as compare to either yeast or mammalian cells.  
Therefore, under normal aerobic condition, the knockdown of APN-1 is expected 
to cause the accumulation of a variety of oxidative DNA lesions that include AP 
sites, base damage, and single strand breaks with blocked 3’-termini.  These 
lesions if not repaired efficiently are expected to cause cell cycle delay, increase 
mutations, as well as giving rise to more toxic lesions such as DNA double strand 
breaks that could lead to cell death.  On the basis of our findings, we anticipate 
that deleting the apn-1 gene would result in mutant animal displaying dramatic 
phenotypes and may even be lethal. 
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